Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             963 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2015
25 S2 p. S677-S702
26 p.
artikel
2 C.06.02 Antipsychotic – side effects and functional impairment in patients with schizophrenia Citrome, L.
2015
25 S2 p. S667-
1 p.
artikel
3 C.13.03 A primary care perspective on the management of patient cases of MDD and cognitive dysfunction Bromley, S.
2015
25 S2 p. S674-
1 p.
artikel
4 C.07.02 Assessment of cognitive dysfunction in patients with depression – which test is best? Harrison, J.
2015
25 S2 p. S669-
1 p.
artikel
5 C.05.02 Assessment of functioning and quality of life in schizophrenia and the relevance for clinical practice Falkai, P.
2015
25 S2 p. S665-S666
2 p.
artikel
6 C.02.02 Augmentation therapies in MDD – what are the unmet needs? Gorwood, P.
2015
25 S2 p. S662-S663
2 p.
artikel
7 C.10.03 Burden of agitation and new guidelines for treatment McAllister-Williams, H.
2015
25 S2 p. S672-
1 p.
artikel
8 C. 01.01 Can DSM-5 improve clinical practice and help to pinpoint at-risk patients? Kupfer, D.J.
2015
25 S2 p. S661-
1 p.
artikel
9 C.03.02 Capturing patient relevant outcomes in depression objectively Harmer, C.
2015
25 S2 p. S664-
1 p.
artikel
10 C.03.01 Depression is more than just low mood Demyttenaere, K.
2015
25 S2 p. S664-
1 p.
artikel
11 C.02.03 Developing D2 partial agonists to optimise augmentation therapy in MDD Stensbol, T.B.
2015
25 S2 p. S663-
1 p.
artikel
12 C.05.03 Do current treatment options differ in terms of functioning and quality of life outcomes in schizophrenia? Kane, J.
2015
25 S2 p. S666-
1 p.
artikel
13 C.02.04 Emerging clinical data in the adjunctive treatment of MDD Thase, M.
2015
25 S2 p. S663-S664
2 p.
artikel
14 C.01.02 Epidemiology of suicide in bipolar disorder Berk, M.
2015
25 S2 p. S661-
1 p.
artikel
15 C.14.01 First witness – cardiovascular risk Hert, M. De
2015
25 S2 p. S674-S675
2 p.
artikel
16 C.08.03 Functioning and living well Molodynski, A.
2015
25 S2 p. S670-S671
2 p.
artikel
17 C.11.04 How can the clinical trial data be translated in to practice? Sinclair, J.
2015
25 S2 p. S673-
1 p.
artikel
18 C.13.01 How I would manage a patient with MDD and occupational impairment Vieta, E.
2015
25 S2 p. S673-S674
2 p.
artikel
19 C.13.02 How I would manage a patient with MDD and substance abuse Baune, B.
2015
25 S2 p. S674-
1 p.
artikel
20 C.01.03 How to use anxiety, irritability, and agitation (AIA) for diagnosing mania with depressive symptoms – patient cases Fagiolini, A.
2015
25 S2 p. S661-S662
2 p.
artikel
21 C. 02.01 Inadequate responses to antidepressant treatments in MDD are frequent and associated with poor functional outcomes Iosifescu, D.
2015
25 S2 p. S662-
1 p.
artikel
22 C.05.01 Long-term treatment goals in schizophrenia Gaebel, W.
2015
25 S2 p. S665-
1 p.
artikel
23 C.11.02 Need for earlier intervention in alcohol dependence – evidence from a large cross-sectional study Rehm, J.
2015
25 S2 p. S672-S673
2 p.
artikel
24 C.06.04 Novel dopamine D2 partial agonists in the treatment of schizophrenia Correll, C.
2015
25 S2 p. S668-
1 p.
artikel
25 C.03.03 Pathways to improve cognitive dysfunction in depression Jaeger, J.
2015
25 S2 p. S664-S665
2 p.
artikel
26 C.11.03 Persistence in treatment, importance of treatment adherence and continued care Kranzler, H.
2015
25 S2 p. S673-
1 p.
artikel
27 C.10.02 Pharmacotherapy of agitation: new routes of administration facilitate de-escalation Zink, M.
2015
25 S2 p. S671-
1 p.
artikel
28 C.08.02 Providing optimal treatment Hargarter, L.
2015
25 S2 p. S670-
1 p.
artikel
29 C.14.02 Second witness – impact on brain architecture De Bartolomeis, A.
2015
25 S2 p. S675-
1 p.
artikel
30 C.06.03 Targeting dopaminergic and serotonergic pathways in schizophrenia Stahl, S.
2015
25 S2 p. S667-
1 p.
artikel
31 C.07.03 The first validated screener for objective and subjective cognitive dysfunction in depression McIntyre, R.
2015
25 S2 p. S669-
1 p.
artikel
32 C.11.01 The natural history of alcohol dependence. Genes, endophenotypes, neurobiology, and course of the disease Brink, W. Van den
2015
25 S2 p. S672-
1 p.
artikel
33 C.08.01 The neurobiological perspective Howes, O.
2015
25 S2 p. S670-
1 p.
artikel
34 C.07.01 The role of cognitive dysfunction in depression and what it means for the patient, clinician and society Lam, R.
2015
25 S2 p. S668-S669
2 p.
artikel
35 C.10.01 The stigma of psychiatric crisis: how to overcome it? Emborg, C.
2015
25 S2 p. S671-
1 p.
artikel
36 C.06.01 The treatment continuum in schizophrenia from the acute phase to maintenance Emsley, R.
2015
25 S2 p. S666-S667
2 p.
artikel
37 C.14.03 Third witness – long-term treatment outcomes Wunderink, L.
2015
25 S2 p. S675-
1 p.
artikel
38 E.02.01 ADHD across the lifespan: neurobiology, treatment and long-term outcome Coghill, D.
2015
25 S2 p. S153-
1 p.
artikel
39 E.06.02 Impact of prenatal exposure to SSRIs or maternal depression disorder on infant developmental outcomes Wisner, K.L.
2015
25 S2 p. S156-
1 p.
artikel
40 E.03.01 Irritability and DSM-5 disruptive mood dysregulation disorder: correlates, predictors, and outcome in children Leibenluft, E.
2015
25 S2 p. S153-S154
2 p.
artikel
41 E.06.01 Maternal and fetal effects of antipsychotic drugs in pregnancy Galbally, M.
2015
25 S2 p. S156-
1 p.
artikel
42 E.03.02 Mood disorders and suicidal ideation and behaviour in children and adolescents Zalsman, G.
2015
25 S2 p. S154-
1 p.
artikel
43 E.07.01 Multiple D2 heteroreceptor complexes in the ventral striatum modulating the brain circuit to the prefrontal cortex – a new target for treatment of schizophrenia Fuxe, K.
2015
25 S2 p. S157-
1 p.
artikel
44 E.04.02 New targets in generalized anxiety disorder Baldwin, D.S.
2015
25 S2 p. S155-
1 p.
artikel
45 E.05.02 Overcoming the treatment gap by implementing existing knowledge – a case for European guidelines in pharmacotherapy? Gaebel, W.
2015
25 S2 p. S155-
1 p.
artikel
46 E.01.01 Psychogenic movement disorders Hallett, M.
2015
25 S2 p. S153-
1 p.
artikel
47 E.04.01 The need for new targets in anxiety disorders – from neurobiology to treatment Van der Wee, N.J.A.
2015
25 S2 p. S154-S155
2 p.
artikel
48 E.07.02 The promised land beyond dopamine – a story of hope and wilderness Kapur, S.
2015
25 S2 p. S157-
1 p.
artikel
49 Keyword Index 2015
25 S2 p. S703-S710
8 p.
artikel
50 KL.01.01 Prosocial primates: cooperation and empathy de Waal, F.B.M.
2015
25 S2 p. S107-
1 p.
artikel
51 P.6.a.001 Alcohol exacerbates restraint stress-induced hippocampal damage and cognitive deficit: implication of poly(ADP)-ribose polymerase over-activation Jangra, A.
2015
25 S2 p. S595-S596
2 p.
artikel
52 P.6.a.006 Alcohol pharmacokinetics in Korean healthy females Nam, B.
2015
25 S2 p. S598-
1 p.
artikel
53 P.1.a.014 Allelic variation in corticotropin-releasing hormone receptor 1 changes receptor activity by alternative splicing Schartner, C.
2015
25 S2 p. S166-S167
2 p.
artikel
54 P.2.a.013 Altered astrocyte function in the pre-limbic cortex and amygdala induces an anxiety and depressive-like phenotype in adult rats McIntosh, A.
2015
25 S2 p. S382-
1 p.
artikel
55 P.5.a.007 Aluminum induced NADPH oxidase expression and mitochondrial dysfunction in a gerbils model of Alzheimer's disease Vucetic-Arsic, S.
2015
25 S2 p. S580-
1 p.
artikel
56 P.2.a.010 Analysis of the rat hippocampal microRNA expression profile following chronic electroconvulsive stimulation Ryan, K.M.
2015
25 S2 p. S380-S381
2 p.
artikel
57 P.2.a.017 Anhedonia induced by individual housing, chronic mild stress or chronic social defeat stress (CSDS) may stem for a different neurochemical phenotype Tordera, R.M
2015
25 S2 p. S384-
1 p.
artikel
58 P.4.a.002 Anxiolytic effects of an orally available nove TSPO antagonist in rodents Katsumata, S.
2015
25 S2 p. S553-
1 p.
artikel
59 P.1.a.010 Association analysis of BRAP polymorphisms on the risk of alcohol dependence and alcohol use disorders identification test Kim, J.W.
2015
25 S2 p. S164-
1 p.
artikel
60 P.1.a.027 Association between the polymorphism of 5-HTTLPR gene and affective temperament dimensions using the TEMPS-A scale in obesity Borkowska, A.
2015
25 S2 p. S172-S173
2 p.
artikel
61 P1.a.011 Association of AHI1 polymorphisms with the diagnosis and treatment outcome of schizophrenia Kim, J.J.
2015
25 S2 p. S164-S165
2 p.
artikel
62 P.1.a.032 Beneficial effects of Sirtuin 2 inhibition in a mouse model of chronic stress Erburu, M.
2015
25 S2 p. S175-
1 p.
artikel
63 P.1.a.015 Brain-Derived Neurotrophic Factor (BDNF) genetic pathway and bipolar disorder Toscano, E.
2015
25 S2 p. S167-
1 p.
artikel
64 P.1.a.006 CACNA1C gene and schizophrenia: A case-control and pharmacogenetic study Porcelli, S.
2015
25 S2 p. S162-
1 p.
artikel
65 P.2.a.009 Chronic administration of buprenorphine in combination with samidorphan produces antidepressant-like effects in rats without locomotor sensitization Burke, N.N.
2015
25 S2 p. S379-S380
2 p.
artikel
66 P.1.a.001 Chronic psychosocial stress and endocannabinoid system interact to affect the transcription of SLC6A4, in the mouse corticostriatal circuits Roig, J. Tomas
2015
25 S2 p. S159-
1 p.
artikel
67 P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect Alboni, S.
2015
25 S2 p. S381-S382
2 p.
artikel
68 P.1.a.012 Common microRNAs in Alzheimer's disease and retinal degenerative diseases Romano, G.L.
2015
25 S2 p. S165-
1 p.
artikel
69 P.1.a.037 Compulsive behaviour in adolescent patients with anorexia nervosa Israelyan, N.
2015
25 S2 p. S177-S178
2 p.
artikel
70 P.1.a.024 Deoxyribonucleic acid methylation marks of psychotropic drug use in bipolar disorder patients; an explorative pilot study Houtepen, L.
2015
25 S2 p. S171-S172
2 p.
artikel
71 P.5.a.006 Dimethyl fumarate improves spatial memory impairments in the rat streptozotocin-induced model of sporadic Alzheimer disease – a pilot study Kurowska, E.
2015
25 S2 p. S579-
1 p.
artikel
72 P1.a.029 Early-life trauma as susceptibility to develop depression in hepatitis C virus patients following long-term treatment with interferon-alpha Plazzotta, G.
2015
25 S2 p. S173-S174
2 p.
artikel
73 P.7.a.001 Effect of cadherin-13 inactivation on hippocampal processes and hippocampus-related behavior: a mouse model for ADHD? Sich, S.
2015
25 S2 p. S634-
1 p.
artikel
74 P.6.a.008 Effect of ethanol on impulsive/compulsive behaviours and on neuronal plasticity gene expression in mice lacking the 5-HT7 receptors Paizanis, E.
2015
25 S2 p. S599-
1 p.
artikel
75 P1.a.013 Effect of HTR7 gene variants on the efficacy of second-generation antipsychotics with 5-HT7R antagonism in Japanese schizophrenia patients Takekita, Y.
2015
25 S2 p. S165-S166
2 p.
artikel
76 P.2.a.001 Effect of sesamol pretreatment against lipopolysaccharide-induced depressive and anxiety-like behaviour in Swiss albino mice Shaker, S. Chandra
2015
25 S2 p. S374-S375
2 p.
artikel
77 P.2.a.014 Effect of subacute and long-term administration of vortioxetine on firing activity of catecholaminergic neurons Ebrahimzadeh, M.
2015
25 S2 p. S382-S383
2 p.
artikel
78 P.1.a.005 Effects of atypical antipsychotics on emotional memory and locomotion: altered gene expression levels of BDNF and CREB in the hippocampus of mice Gumuslu, E.
2015
25 S2 p. S161-S162
2 p.
artikel
79 P.5.a.009 Effects of chronic streptozocin-induced diabetes on neural stem cell proliferation in the 5XFAD mouse model of Alzheimer's disease Sonn, K.
2015
25 S2 p. S580-S581
2 p.
artikel
80 P.1.a.022 Effects of parabolic flight on epigenetics-related gene expression in the mouse brain Yoshioka, M.
2015
25 S2 p. S170-
1 p.
artikel
81 P.2.a.002 Experimental investigation on the effects of some antidepressants on spatial memory performance of old rats Popa, E.G.
2015
25 S2 p. S375-S376
2 p.
artikel
82 P.4.a.004 Fear extinction deficits and BDNF dysregulation in mice with full 5-HT2C receptor editing: a model for post-traumatic stress disorders? Regue, M.
2015
25 S2 p. S554-S555
2 p.
artikel
83 P.1.a.007 Four polymorphisms of SLC6A4 are novel predictors of SSRI/SNRI response in depressive disorder: sequencing analysis of SLC6A4 Kato, M.
2015
25 S2 p. S162-S163
2 p.
artikel
84 P.1.a.021 Genetic and epigenetic regulation of cannabinoid receptor type-1 in obesity Pucci, M.
2015
25 S2 p. S169-S170
2 p.
artikel
85 P.1.a.003 Genetic polymorphisms of chimerin-1 in schizophrenia and ischemic stroke Tadevosyan, K.
2015
25 S2 p. S160-S161
2 p.
artikel
86 P.1.a.002 Genetics of long-term treatment outcome in bipolar disorder Fabbri, C.
2015
25 S2 p. S159-S160
2 p.
artikel
87 P.1.a.034 Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease: a systematic review Signorelli, M.S.
2015
25 S2 p. S175-S176
2 p.
artikel
88 P.6.a.004 Habitual alcohol drinking behavior associated with active ghrelin and serotonin neurons in the amygdala and lateral hypothalamus Yoshimoto, K.
2015
25 S2 p. S597-S598
2 p.
artikel
89 P1.a.023 Impact of a SNP in SIGMAR1 on major depression, bipolar disorder and treatment response Mandelli, L.
2015
25 S2 p. S170-S171
2 p.
artikel
90 P.4.a.001 Impulsivity features of patients with obsessive-compulsive disorder and relationship between impulsivity and obsession subtypes Onur, O.
2015
25 S2 p. S552-S553
2 p.
artikel
91 P.6.a.002 Increased [3h]quisqualic acid binding density in the dorsal striatum of alcoholics Laukkanen, V.
2015
25 S2 p. S596-
1 p.
artikel
92 P.4.a.007 Individual- and area-level risk factors of generalised anxiety disorder in a British community cohort: findings from the EPIC-Norfolk study Remes, O.
2015
25 S2 p. S556-
1 p.
artikel
93 P.1.a.016 Investigating schizophrenia genome-wide association studies risk variants in cognitive and neuroimaging defects in the GENUS Consortium collection Petryshen, T.
2015
25 S2 p. S167-S168
2 p.
artikel
94 P4.a.003 Involvement of CYP2C19 in stress-induced despair Jukić, M.M
2015
25 S2 p. S553-S554
2 p.
artikel
95 P.1.a.031 Lifetime stress accelerates epigenetic aging Zannas, A.
2015
25 S2 p. S174-S175
2 p.
artikel
96 P.1.a.035 Methyltransferase gene polymorphism determines schizophrenia symptom severity at the stage of the clinical outcome in females Nestsiarovich, A.
2015
25 S2 p. S176-
1 p.
artikel
97 P.2.a.003 Modulation of antidepressant and pro-depressive-like effect of food restriction according to the light/dark cycle schedule Martynhak, B.
2015
25 S2 p. S376-
1 p.
artikel
98 P.1.a.008 Oxytocin receptor gene hypomethylation as a potential risk factor in social anxiety? Ziegler, C.
2015
25 S2 p. S163-S164
2 p.
artikel
99 P.1.a.028 Pattern of expression in different stages of schizophrenia: comparing induced pluripotent stem cell-derived neurons with post mortem cerebral cortex Manchia, M.
2015
25 S2 p. S173-
1 p.
artikel
100 P.1.a.018 Personalised medicine in psychiatry – pharmacogenetics of antidepressant response in obsessive-compulsive disorder Zai, G.
2015
25 S2 p. S168-
1 p.
artikel
101 P.5.a.005 Preventive effect of the natural monoterpene myrtenal on cognitive disorders in dement mice Dragomanova, S.
2015
25 S2 p. S578-S579
2 p.
artikel
102 P.2.a.008 Pro-depressive-like effects of mGlu4 selective agonist LSP4–2022 in mice Rzezniczek, S.
2015
25 S2 p. S379-
1 p.
artikel
103 P.4.a.005 Role of 5-HT3 receptors in depression-related behaviors and antidepressant treatments Martin, V
2015
25 S2 p. S555-
1 p.
artikel
104 P.2.a.005 Screening for novel antidepressants with the forced swim test: the case of females Kokras, N.
2015
25 S2 p. S377-
1 p.
artikel
105 P.6.a.007 Stopping hand and eye movements during acute alcohol intoxication Campbell, A.
2015
25 S2 p. S598-S599
2 p.
artikel
106 P.2.a.011 Study of microRNA-related single-nucleotide polymorphisms in major depression Maffioletti, E.
2015
25 S2 p. S381-
1 p.
artikel
107 P.1.a.036 Subclinical psychotic experiences in healthy adults: relationship between genetic variants of FKBP5 gene, neuroticism and childhood trauma Mihaljevic, M.
2015
25 S2 p. S177-
1 p.
artikel
108 P.2.a.004 Sustained aromatase inhibition: brain effects in both sexes Dalla, C.
2015
25 S2 p. S376-S377
2 p.
artikel
109 P.2.a.006 Task- and treatment-dependent effects of vortioxetine on scopolamine-induced cognitive dysfunction and cortical extracellular acetylcholine Pehrson, A.
2015
25 S2 p. S378-
1 p.
artikel
110 P.1.a.019 The association between MFN2 (mitofusin 2) gene polymorphism and late-onset Alzheimer's disease in Korean population Song, J.Y.
2015
25 S2 p. S169-
1 p.
artikel
111 P.2.a.015 The effect of antidepressant treatment during pregnancy on social behaviour in the offspring Houwing, D.J.
2015
25 S2 p. S383-
1 p.
artikel
112 P.1.a.025 The effect of maternal bonding and the CHRNB2 gene on smoking-related depressive symptoms Csala, I.
2015
25 S2 p. S172-
1 p.
artikel
113 P.5.a.001 The effect of novel tacrine-related cholinesterase inhibitors on cognitive deficit induced by 3-quinuclidinyl benzilate in rats Kassa, J.
2015
25 S2 p. S577-
1 p.
artikel
114 P.2.a.016 The effects of buprenorphine in combination with samidorphan on neurochemical and behavioral measures in Wistar Kyoto rats Cunningham, J.I
2015
25 S2 p. S384-
1 p.
artikel
115 P.1.a.004 The new genetic markers of development syndromes associated with intellectual disability in Armenian population Mironava, K.
2015
25 S2 p. S161-
1 p.
artikel
116 P.2.a.007 The potential antidepressant effect of the joint administration of ketamine and mGLU2/3 receptor antagonist, LY341495 in the forced swim test in rats Podkowa, K.
2015
25 S2 p. S378-S379
2 p.
artikel
117 P.5.a.002 Therapeutic effect of novel 7-methoxytacrine-donepezil like hybrids on cognitive deficit in rats – a potentiality for Alzheimer's disease treatment Kassa, J.
2015
25 S2 p. S577-S578
2 p.
artikel
118 P.4.a.006 The role of nerve growth factor and its receptor in posttraumatic stress disorder Avetyan, D.
2015
25 S2 p. S555-S556
2 p.
artikel
119 P.6.a.003 Thyrotropin-releasing hormone and its synthetic pentapeptide analog antagonize destructive changes produced by ethanol in the rat brain Pronko, P.
2015
25 S2 p. S597-
1 p.
artikel
120 P.5.a.004 Trasient receptor potential ankyrin 1 (TRPA1): a novel relevant target in Alzheimer's disease? Assunção Bicca, M.
2015
25 S2 p. S578-
1 p.
artikel
121 P.3.b.003 Abnormal connectivity in precuneus in schizophrenia patients and unaffected relatives Galindo, L.
2015
25 S2 p. S464-
1 p.
artikel
122 P.7.b.006 Abnormal functional architecture of amygdala-centered networks in adolescent posttraumatic stress disorder Aghajani, M.
2015
25 S2 p. S637-S638
2 p.
artikel
123 P.1.b.026 Abnormalities in the auditory and frontal cortices in a mouse model of 22q11.2 Deletion Syndrome Zinnamon, F.A.
2015
25 S2 p. S192-S193
2 p.
artikel
124 P.3.b.013 Adolescents with family history of psychosis and the effect of family environment on the antioxidant defense system García-Alocén, A.
2015
25 S2 p. S470-S471
2 p.
artikel
125 P.2.b.006 Age at onset in a sample of bipolar patients: clinical features and psychiatric comorbidity Matteo, P.
2015
25 S2 p. S388-
1 p.
artikel
126 P.1.b.014 Agenesis of corpus callosum: incidental finding in a schizophrenic patient – a case report Guerzoni, G.
2015
25 S2 p. S185-S186
2 p.
artikel
127 P.1.b.023 Aggression-related brain function assessed with the point subtraction aggression paradigm in functional magnetic resonance imaging Skibsted, A.P.
2015
25 S2 p. S191-
1 p.
artikel
128 P.2.b.035 Agomelatine safety: monitoring liver function in observational study De Santiago, A.I.
2015
25 S2 p. S404-S405
2 p.
artikel
129 P.6.b.006 Alcohol hangover amongst Canadian university students: can hangover immunity be really claimed? Verster, J.C.
2015
25 S2 p. S603-
1 p.
artikel
130 P.6.b.011 Alexithymia in a sample of alcohol-dependent patients: clinical correlations and cognitive patterns Vecchiotti, R.
2015
25 S2 p. S605-S606
2 p.
artikel
131 P.2.b.016 A longitudinal study of the relationships between anhedonia and functioning in a large cohort of depressed patients treated by general practitioners Gourion, D.
2015
25 S2 p. S393-S394
2 p.
artikel
132 P.1.b.024 Altered structural plasticity in acute and remitted depressive patients investigated with ultra-high field magnetic resonance imaging Kraus, C.
2015
25 S2 p. S191-S192
2 p.
artikel
133 P.6.b.005 An fMRI study of nalmefene on alcohol effects in reward anticipation in alcohol dependence Lingford-Hughes, A.
2015
25 S2 p. S602-S603
2 p.
artikel
134 P.2.b.022 Antidepressant effect and tolerabilty of agomelatine in smokers/non-smokers/ex-smokers: results of a subgroup-analysis over 6 months (VITAL-study) Lemke, M.R.
2015
25 S2 p. S397-S398
2 p.
artikel
135 P.5.b.009 Are antidepressant drugs safer than antipsychotics in the behavioural and psychological symptoms of dementia? Zangrando, A.
2015
25 S2 p. S585-S586
2 p.
artikel
136 P.8.b.005 Assessment of patients with morbid obesity prior to bariatric surgery (sleeve gastrectomy) Garayeva, K.
2015
25 S2 p. S656-
1 p.
artikel
137 P.7.b.001 Assessment of theory of mind and empathy skills of typically developing siblings of children diagnosed with autism spectrum disorder Eyuboglu, M.
2015
25 S2 p. S635-
1 p.
artikel
138 P.2.b.019 Association between clinical response to duloxetine treatment and brain-derived neurotrophic factor or catecholamine metabolites Atake, K.
2015
25 S2 p. S395-S396
2 p.
artikel
139 P.4.b.002 Association of human microRNAs miR-22 and miR-491 polymorphisms with panic disorder with or without agoraphobia in a Korean population Lee, K.S
2015
25 S2 p. S557-S558
2 p.
artikel
140 P.5.b.008 A systematic review and meta-analysis update of propentofylline for dementia Frampton, M.
2015
25 S2 p. S585-
1 p.
artikel
141 P.8.b.001 A systematic review of the effectiveness of psychological interventions for adult sex-offenders in prisons, community clinics and forensic hospitals Harsh, R.
2015
25 S2 p. S653-S654
2 p.
artikel
142 P.4.b.001 Baseline heartbeat perception accuracy and short-term outcome of brief cognitive-behaviour therapy for panic disorder with agoraphobia Masdrakis, V.
2015
25 S2 p. S556-S557
2 p.
artikel
143 P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study Di Volo, S.
2015
25 S2 p. S656-S657
2 p.
artikel
144 P.4.b.005 Changes in high frequency oscillations (HFOs) in anxiety disorders: a pilot study Hatzigiakoumis, D.S
2015
25 S2 p. S559-
1 p.
artikel
145 P.3.b.024 Changes in white matter microstructure integrity of the limbic system after psychosis in 22q11 deletion syndrome seems to be associated with psychosis Bakker, I.M.
2015
25 S2 p. S477-S478
2 p.
artikel
146 P.1.b.004 Chronic supplementation with thiamine enhances the anticonvulsant effect of diazepam on pentylenetetrazole induced seizure in mice Mesdaghinia, A.
2015
25 S2 p. S179-S180
2 p.
artikel
147 P.2.b.001 Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, adult outpatients with major depressive disorder Srisurapanont, M.
2015
25 S2 p. S385-
1 p.
artikel
148 P.5.b.002 Clinical correlates of apathy in patients with Alzheimer's disease Cobanoglu, E.
2015
25 S2 p. S582-
1 p.
artikel
149 P.1.b.018 Clustering of emotional processing data in subjects with generalised anxiety disorder and major depression Hilbert, K.
2015
25 S2 p. S188-
1 p.
artikel
150 P.5.b.001 Cochrane review of valproate preparations for agitation in dementia Narayana, U.
2015
25 S2 p. S581-S582
2 p.
artikel
151 P.6.b.015 Cognitive endophenotypes in alcohol dependence: risk-taking decision-making and impulsivity differences between patients and first-degree relatives Gál, B.I
2015
25 S2 p. S608-
1 p.
artikel
152 P.2.b.023 Cognitive impairment in patients with major depression and inadequate response to antidepressants Umbricht, D.
2015
25 S2 p. S398-
1 p.
artikel
153 P.3.b.009 Communication skills and their relation to cognition and the severity of psychopathology symptoms in chronic schizophrenia outpatients Adamczyk, P.
2015
25 S2 p. S468-
1 p.
artikel
154 P.2.b.034 Comparative effects of ziprasidone and quetiapine on sleep physiology measures in patients with major depressive disorders and insomnia Miljatovic, A.
2015
25 S2 p. S404-
1 p.
artikel
155 P.5.b.005 Comparing the alexithymia features between individuals with subjective cognitive decline and mild cognitive impairment Batun, G. Cetiner
2015
25 S2 p. S583-
1 p.
artikel
156 P.6.b.010 Comparison of HPA axis response to the stimulation of psychological stress in abstinence period of alcoholism with first degree relatives and control Kütük, E. Koyuncu
2015
25 S2 p. S604-S605
2 p.
artikel
157 P3.b.004 COMT × DRD2 epistasis modulates a putative emotional connectomic intermediate phenotype for schizophrenia Cao, H.
2015
25 S2 p. S464-S465
2 p.
artikel
158 P.8.b.004 Correlation of group education with metabolic and psychosocial parameters in type 2 diabetes patients Bakomitrou, F.
2015
25 S2 p. S655-S656
2 p.
artikel
159 P.3.b.002 Cortex morphology and subcortical brain grey matter deficits in schizophrenia and unaffected relatives Pastoriza, F.
2015
25 S2 p. S463-S464
2 p.
artikel
160 P.3.b.023 Decreased intrinsic connectivity within mesocortical networks associated with apathy in patients with schizophrenia Xu, P.
2015
25 S2 p. S476-S477
2 p.
artikel
161 P.2.b.025 Default mode network dominance over the task positive network is not increased in remitted depressed patients at high risk for recurrence Figueroa, C.
2015
25 S2 p. S399-
1 p.
artikel
162 P.2.b.007 Depression and the cognitive distortions among the patients with end stage renal disease Tuna, O.C
2015
25 S2 p. S388-S389
2 p.
artikel
163 P.6.b.014 Detection of alcohol problems: the sooner the best Boticario, V.
2015
25 S2 p. S607-S608
2 p.
artikel
164 P.2.b.005 Determining factors for discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder Kazutaka, S.
2015
25 S2 p. S387-
1 p.
artikel
165 P.3.b.026 Differences in cortical morphology between 22q11.2 deletion syndrome patients and patients at ultra-high risk for psychotic disorders Bakker, G.
2015
25 S2 p. S478-
1 p.
artikel
166 P.7.b.009 Different brain responses during empathy in youth with autism spectrum disorders and youth with conduct disorder and callous-unemotional traits Klapwijk, E.T.
2015
25 S2 p. S640-
1 p.
artikel
167 P.1.b.016 Differential features of allodynia associated with cephalic versus extra-cephalic neuropathic pain in rats Michot, B.
2015
25 S2 p. S186-S187
2 p.
artikel
168 P.6.b.016 Disulfiram psychosis in the treatment of alcoholism Mota, D.
2015
25 S2 p. S608-S609
2 p.
artikel
169 P.1.b.012 Dopamine release in the prefrontal cortex: implications for the stimulant emission tomography paradigm Hernaus, D.
2015
25 S2 p. S184-
1 p.
artikel
170 P.3.b.012 Duration of untreated psychosis and cognitive impairment Rebhi, H.
2015
25 S2 p. S469-S470
2 p.
artikel
171 P.1.b.032 Effectiveness of the combination of ECT and pharmacological drugs in patients with different diagnosis and description of the incidences observed Nunez, N.I.
2015
25 S2 p. S195-S196
2 p.
artikel
172 P.2.b.018 Effect of accumulation of 5-HTTLPR, BDNF Vall66Met and COMT Val158Met polymorphisms on brain morphology in patients with major depressive disorder Kostic, M.
2015
25 S2 p. S395-
1 p.
artikel
173 P.3.b.016 Effect of haloperidol and olanzapine on clock genes expression – preliminary results Mokros, L.
2015
25 S2 p. S472-
1 p.
artikel
174 P.1.b.006 Effect of physical exercise on the firing activity of serotonin neurons in rats Dremencov, E.
2015
25 S2 p. S181-
1 p.
artikel
175 P.1.b.030 Effects of acute restraint stress on prepulse inhibition of the acoustic startle response in Wistar rats da Silva, R.C. Barbosa
2015
25 S2 p. S194-
1 p.
artikel
176 P.2.b.032 Effects of adjuvant endocrine therapy on depression and quality of life in early breast cancer patients Ristevska-Dimitrovska, G.
2015
25 S2 p. S403-
1 p.
artikel
177 P.1.b.019 Effects of antipsychotic treatment on the proteins of glutamatergic synapse in the brain of rats perinatally treated with phencyclidine Petronijevic, N.
2015
25 S2 p. S188-S189
2 p.
artikel
178 P.3.b.014 Effects of depressive symptoms and social functioning level for hospitalizations of schizophrenia patients with community-based mental health model Varlik, C.
2015
25 S2 p. S471-
1 p.
artikel
179 P.1.b.017 Effects of zinc treatment on the 5-HT1A receptor function: behavioural responses Szewczyk, B.
2015
25 S2 p. S187-S188
2 p.
artikel
180 P.2.b.009 Environmental effects on suicidal behaviour: association of drinking-water arsenic levels and suicide Gonda, X.
2015
25 S2 p. S389-S390
2 p.
artikel
181 P.6.b.002 Epidemiology and diffusion binge drinking phenomenon in an Italian population of young adults Lupi, M.
2015
25 S2 p. S600-S601
2 p.
artikel
182 P.7.b.002 Epilepsy and EEG paroxysmal abnormalities associated with autism spectrum disorders Jovic, N.J.
2015
25 S2 p. S635-S636
2 p.
artikel
183 P.3.b.001 Exploring shared and variant alterations in brain function between schizophrenia and bipolar disorder using resting-state fMRI Visintin, E.
2015
25 S2 p. S462-S463
2 p.
artikel
184 P.1.b.008 Eye movement desensitization and reprocessing (EMDR) efficacy on characteristic post-traumatic stress disorder neurobiological alterations Casolaro, I.
2015
25 S2 p. S182-
1 p.
artikel
185 P.4.b.010 Fear conditioning and BDNF levels and genotype in obsessive-compulsive disorder patients pre and post treatment with sertraline: preliminary results Diniz, J.
2015
25 S2 p. S562-S563
2 p.
artikel
186 P.3.b.018 Gene polymorphisms of oxidative stress and glutamatergic system in schizophrenic patients with tardive dyskinesia Boiko, A.
2015
25 S2 p. S473-S474
2 p.
artikel
187 P.3.b.022 Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with psychotic disorders Curčić-Blake, B.
2015
25 S2 p. S476-
1 p.
artikel
188 P.1.b.015 Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease people Jeong, H.
2015
25 S2 p. S186-
1 p.
artikel
189 P.4.b.003 High trait anxiety promotes memory for threat-congruent faces under threat of unpredictable shock Hindocha, C.
2015
25 S2 p. S558-
1 p.
artikel
190 P.2.b.004 Homocysteine and asymmetric dimethylarginine in bipolar depression: the effect of pharmacological treatment Permoda-Osip, A.
2015
25 S2 p. S386-S387
2 p.
artikel
191 P.8.b.008 How pregnancy changes psychoactive drugs – pharmacokinetic implications in clinical practice Alves, S.
2015
25 S2 p. S658-
1 p.
artikel
192 P.1.b.007 Idiopathic acute polyradiculoneuritis concurrent with acquired myasthenia gravis or a separate entity in a West Highland White Terrier dog? Stanciu, G.D.
2015
25 S2 p. S181-S182
2 p.
artikel
193 P.2.b.027 Impaired down-regulation of negative emotion in self-referent social situations in bipolar disorder: a pilot study of a novel experimental paradigm Kjærstad, H.L
2015
25 S2 p. S400-S401
2 p.
artikel
194 P.7.b.003 Incorporating a clinical staging model to a sample of children and adolescent offspring of schizophrenia, bipolar and community control Sanchez-Gistau, V.
2015
25 S2 p. S636-
1 p.
artikel
195 P.2.b.008 Increased cerebrospinal fluid fibrinogen delineates a subgroup of major depressive disorder Hattori, K.
2015
25 S2 p. S389-
1 p.
artikel
196 P.4.b.008 Inflammatory related pathways and SGK1 signaling as targets of early life stressful events: role of DNA methylation and microRNAs Cattaneo, A.
2015
25 S2 p. S561-
1 p.
artikel
197 P.6.b.001 Influence of NLPR3 and CARD8 inflammasome on expression of alcohol related psychopathological symptoms in alcohol addicted subjects Plemenitas, A.
2015
25 S2 p. S600-
1 p.
artikel
198 P.8.b.009 Inhaled loxapine for the acute treatment of agitation: clinical experience from eastern and northern Finland Maaranen, P.
2015
25 S2 p. S658-S659
2 p.
artikel
199 P.3.b.007 Insight in schizophrenia: the role of neurocognitive functioning in relation to psychopathology Youn, T.
2015
25 S2 p. S466-S467
2 p.
artikel
200 P.1.b.022 Integration and segregation of default mode network resting-state functional connectivity in high-functioning autism spectrum disorder Joshi, G.
2015
25 S2 p. S190-S191
2 p.
artikel
201 P.3.b.021 Interleukin-1β, cognition and metabolic syndrome in schizophrenia Bosia, M.
2015
25 S2 p. S475-S476
2 p.
artikel
202 P.4.b.006 Intranasal oxytocin attenuates amygdala functional connectivity after a trauma reminder in recently trauma-exposed individuals Frijling, J.
2015
25 S2 p. S560-
1 p.
artikel
203 P.2.b.002 Life events in childhood and before onset in major depression. prevalence, specificity and their impact on disease features and causal relationships Mandelli, L.
2015
25 S2 p. S385-S386
2 p.
artikel
204 P.8.b.003 Light therapy as a treatment for sexual dysfunction Koukouna, D.
2015
25 S2 p. S655-
1 p.
artikel
205 P.2.b.011 Low-dose interferon-alpha induced depression is significantly alleviated by social support in melanoma patients: potential biological explanations Kovacs, P.
2015
25 S2 p. S391-
1 p.
artikel
206 P.3.b.010 Low erythrocyte catalase activity in patients with schizophrenia Krivokapic, Z.
2015
25 S2 p. S468-S469
2 p.
artikel
207 P.2.b.013 Lurasidone for the treatment of major depressive disorder with mixed features: a randomised, double-blind, placebo-controlled 6 week trial Suppes, T.
2015
25 S2 p. S391-S392
2 p.
artikel
208 P.6.b.007 Measurement of hangover severity: can a 1-item question replace multi-item scales? Hogewoning, A.
2015
25 S2 p. S603-S604
2 p.
artikel
209 P.5.b.007 Mechanisms underpinning antipsychotic drug sensitivity in Alzheimer's disease Reeves, S.
2015
25 S2 p. S584-S585
2 p.
artikel
210 P.6.b.003 Nalmefene in alcohol-related disorder and major depressive disorder de Diego, B.O. Plasencia Garcia
2015
25 S2 p. S601-
1 p.
artikel
211 P.1.b.029 Neurobiological correlates of aberrant motor functioning in schizophrenia Neves, B. Costa
2015
25 S2 p. S193-S194
2 p.
artikel
212 P.6.b.013 Neurochemical and microstructural aberrancies in binge alcohol consumption Morris, L.
2015
25 S2 p. S606-S607
2 p.
artikel
213 P.1.b.003 Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and of its reversal by risperidone Figueras, M. Rabella
2015
25 S2 p. S179-
1 p.
artikel
214 P.1.b.005 On the balance and distribution of adenosine A2A homoreceptor and A1-A2A isoreceptor complexes in the hippocampus of the rat brain Escuela, D.O. Borroto
2015
25 S2 p. S180-S181
2 p.
artikel
215 P.1.b.013 Opioid and dopamine transmission in chronic pain and health are diametrically opposed: a phMRI study Bourke, J.
2015
25 S2 p. S184-S185
2 p.
artikel
216 P.3.b.008 Perception of sarcasm in the course of psychosis and its correlation to clinical symptomatology Ntouros, E.
2015
25 S2 p. S467-
1 p.
artikel
217 P.2.b.021 Pharmacologic treatment patterns and social functioning in depressive outpatients Pirlog, M.
2015
25 S2 p. S396-S397
2 p.
artikel
218 P.4.b.004 Photosensitivity in panic disorder and effects of medication treatment Campinoti, G.
2015
25 S2 p. S558-S559
2 p.
artikel
219 P.3.b.011 Plasma nuclear factor kappa level in patients with schizophrenia and comparison with healthy controls Tasdemir, A.
2015
25 S2 p. S469-
1 p.
artikel
220 P.3.b.015 Positive encenicline exposure-response relationships for cognition and clinical function in schizophrenia patients receiving atypical antipsychotics Loewen, G.
2015
25 S2 p. S471-S472
2 p.
artikel
221 P.3.b.017 Progesterone and dehydroepiandrosterone levels in a sample of psychotic drug-free patients Serati, M.
2015
25 S2 p. S473-
1 p.
artikel
222 P.7.b.008 Progressive loss of gray matter volume in the frontal lobe is associated with decreased working memory performance over time in adolescent psychosis Arenzana, M. Villar
2015
25 S2 p. S639-S640
2 p.
artikel
223 P.7.b.007 Psychiatric comorbidity in children with autism spectrum disorders and association with maternal emotional manifestations Boussaid, N.
2015
25 S2 p. S638-
1 p.
artikel
224 P.2.b.024 Psychosocial burden of unipolar and bipolar depression in the course of disease during three subsequent depressive episodes Gosek, P.
2015
25 S2 p. S398-S399
2 p.
artikel
225 P.6.b.004 Quetiapine XR reduces impulsivity and dissociation in a sample of alcoholic patients Preve, M.
2015
25 S2 p. S602-
1 p.
artikel
226 P.8.b.007 Relation between the presence of obesogenic behaviors and the outcome of bariatric surgery Fuentes, M.
2015
25 S2 p. S657-S658
2 p.
artikel
227 P.2.b.026 Retinal nerve fiber layer structure abnormalities in major depressive patients treated with repetitive TMS: preliminary results Gene, A.
2015
25 S2 p. S400-
1 p.
artikel
228 P.1.b.027 Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia Canali, P.
2015
25 S2 p. S193-
1 p.
artikel
229 P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease Sun, Y.
2015
25 S2 p. S403-S404
2 p.
artikel
230 P.7.b.005 Sleep patterns in children with autism spectrum disorder – a comparative study with a general pediatric population Paraipan, C.
2015
25 S2 p. S637-
1 p.
artikel
231 P.2.b.028 Somatic comorbidity in patients with depressive or anxiety disorders: prevalence and associated factors Mahia, M.C. Garcia
2015
25 S2 p. S401-
1 p.
artikel
232 P.2.b.031 Stressful life events, memory performance and HPA axis negative feedback sensitivity in major depression: a structural equation modelling approach Soria, V.
2015
25 S2 p. S402-S403
2 p.
artikel
233 P.2.b.017 Structural brain alterations in major depression: findings from the ENIGMA Major Depressive Disorder Working Group Schmaal, L.
2015
25 S2 p. S394-S395
2 p.
artikel
234 P.1.b.020 Subcortical volumes across the life span in ADHD: an ENIGMA collaboration Hoogman, M.
2015
25 S2 p. S189-
1 p.
artikel
235 P.1.b.009 Suicide attempts are associated with hippocampal volumes in depressed patients, independently from previous antidepressant treatments Colle, R.
2015
25 S2 p. S182-S183
2 p.
artikel
236 P.5.b.006 Tandospirone for anxiety and agitation in frontotemporal dementia Hashimoto, Y.
2015
25 S2 p. S584-
1 p.
artikel
237 P.1.b.031 The adenosine 1 receptor modulates basal synaptic activity in the pre-frontal cortex De Leeuw, S.M.
2015
25 S2 p. S194-S195
2 p.
artikel
238 P.3.b.020 The association between dorsolateral prefrontal N-acetylaspartate and insight in psychotic disorders Larabi, D.I.
2015
25 S2 p. S474-S475
2 p.
artikel
239 P.1.b.002 The EEG specificity in children with attention deficit hyperactivity disorder (ADHD) Khachidze, I.
2015
25 S2 p. S178-S179
2 p.
artikel
240 P.1.b.011 The effect of a combination of D-cycloserine treatment and extinction therapy on M1 protein expression in rats traumatised with cat odor Gören, M.Z.
2015
25 S2 p. S183-S184
2 p.
artikel
241 P.8.b.002 The effect of dietary intake of vitamin B6 on sleep quality and insomnia Peters, L.
2015
25 S2 p. S654-S655
2 p.
artikel
242 P.5.b.003 The effect of memantine treatment for sleep disturbances in patients with alcohol-related dementia Shin, D.
2015
25 S2 p. S582-S583
2 p.
artikel
243 P.3.b.006 The effect of thought disorders on psychosocial functioning in schizophrenia Yalincetin, B.
2015
25 S2 p. S466-
1 p.
artikel
244 P.6.b.012 The effects of combined transcranial direct current stimulation and alcohol avoidance training as a treatment for alcoholic inpatients Uyl, T.E. Den
2015
25 S2 p. S606-
1 p.
artikel
245 P.6.b.008 The impact of consuming food or drinking water on alcohol hangover Kösem, Z.
2015
25 S2 p. S604-
1 p.
artikel
246 P.4.b.007 The lucidity features and dream anxiety level in elderly patients with generalized anxiety disorder Zakirov, F.
2015
25 S2 p. S560-S561
2 p.
artikel
247 P.2.b.020 The metacognitive functioning in bipolar patients and in bipolar alcoholic patients Vecchiotti, R.
2015
25 S2 p. S396-
1 p.
artikel
248 P.2.b.003 The most serious past suicidal ideation as a unique risk factor for suicide behaviours in depression Jung, M.H.
2015
25 S2 p. S386-
1 p.
artikel
249 P.3.b.005 Theory of mind, experiential negative symptoms and schizophrenia Gotor, F.
2015
25 S2 p. S465-S466
2 p.
artikel
250 P.2.b.036 The outcome of major depressive disorder comorbid diabetes Ju, P.
2015
25 S2 p. S405-S406
2 p.
artikel
251 P.2.b.014 The use of smartphone app for early detection of manic or depressive episodes in affective patients Hess, S.
2015
25 S2 p. S392-
1 p.
artikel
252 P.8.b.010 The use of SSRI agents in treatment of female sexual desire disorder Nersisyan, N.
2015
25 S2 p. S659-
1 p.
artikel
253 P.2.b.030 The validation of Premenstrual Symptoms Screening Tool (PSST) in the Greek population: Preliminary results Karaoulanis, S.
2015
25 S2 p. S401-S402
2 p.
artikel
254 P.4.b.009 The white ‘matter’ in obsessive compulsive disorder: effect of pharmacological treatment and symptom dimensions models Muzzarelli, L.
2015
25 S2 p. S561-S562
2 p.
artikel
255 P.2.b.010 Treatment of night eating syndrome in patients with major depressive disorder Makhortova, I.S
2015
25 S2 p. S390-
1 p.
artikel
256 P.2.b.015 Which pregnant bipolar women have an increased risk of delayed psychiatric treatment? Serati, M.
2015
25 S2 p. S392-S393
2 p.
artikel
257 P.1.b.021 Why electroencephalography is a powerful tool to identify translational biomarkers for psychiatric disorders? Duveau, V.
2015
25 S2 p. S190-
1 p.
artikel
258 P.3.b.019 Will schizoaffective disorder survive the era of DSM-5? Izakova, L.
2015
25 S2 p. S474-
1 p.
artikel
259 P.1.c.010 Access to diagnosis, treatment and supportive services: results from the caregiver perspective on pediatric ADHD study in Europe Fridman, M.
2015
25 S2 p. S199-S200
2 p.
artikel
260 P.4.c.004 Adult neuroplasticity as a pathological trigger of recurrence in depression Alves, N.
2015
25 S2 p. S564-S565
2 p.
artikel
261 P.4.c.005 Agmatine attenuates oxidative damage in chronic unpredictable mild stress model in rats Aricioglu, F.
2015
25 S2 p. S565-
1 p.
artikel
262 P.3.c.003 AUT6, a novel Kv3 channel modulator, reverses cognitive and neurobiological dysfunction in a rat model of relevance to schizophrenia symptomatology Leger, M.
2015
25 S2 p. S480-
1 p.
artikel
263 P.2.c.008 Cell therapy as a strategy for the treatment of bipolar disorder: preliminary results of a study using an animal model of mania Ascoli, B.
2015
25 S2 p. S410-
1 p.
artikel
264 P.6.c.003 Changes of the 5-HT1B receptors protein level after chronic amphetamine self-administration and its withdrawal in designated structures of rat brain Miszkiel, J.
2015
25 S2 p. S610-
1 p.
artikel
265 P.1.c.015 Cognitive development in 4-to 6-year old children: does the Cambridge neuropsychological test automated battery provide a reliable assessment? Grummitt, J.
2015
25 S2 p. S203-
1 p.
artikel
266 P.7.c.001 Correction of negative effects of acute normobaric hypoxia in rats with a synthetic analog of ACTH Sukhanova, I.
2015
25 S2 p. S640-S641
2 p.
artikel
267 P.2.c.001 Determining the CNS effects of ebselen: a potential lithium-mimetic Singh, N.
2015
25 S2 p. S406-
1 p.
artikel
268 P.6.c.001 Dopamine D2 receptor dynamic and modulation in the D2R-Sigma 1 heteroreceptor complexes: role in cocaine action Pinton, L.
2015
25 S2 p. S609-S610
2 p.
artikel
269 P.4.c.002 Efficacy of ECT in ultrasound induced depression in rats Morozova, A.
2015
25 S2 p. S563-S564
2 p.
artikel
270 P.1.c.013 Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children with ADHD: A new electrocardiographic T-waves marker Lamberti, M.
2015
25 S2 p. S201-S202
2 p.
artikel
271 P.2.c.006 Extensity and dispersion of personality disorder in bipolar patients Ustün, N.
2015
25 S2 p. S408-S409
2 p.
artikel
272 P.4.c.003 Fluoxetine effect on neuronal differentiation in human embryonic carcinoma cells Park, J.E.
2015
25 S2 p. S564-
1 p.
artikel
273 P.2.C.002 Gene expression profile of DGKH risk variant carriers with bipolar disorder Kittel-Schneider, S.
2015
25 S2 p. S406-S407
2 p.
artikel
274 P.1.c.003 Generation of human iPSC-derived neural stem/progenitor cells and their differentiation into glutamatergic and GABAergic neurons Schiller, J.
2015
25 S2 p. S196-
1 p.
artikel
275 P.3.c.005 Impact of antipsychotic treatment on levels of glucose, cholesterol and triacylglycerol in serum of rats perinatally treated with phencyclidine Velimirović, M.
2015
25 S2 p. S480-S481
2 p.
artikel
276 P.4.c.008 Influence of tianeptine on LPS-induced BDNF expression in olfactory bulbs of female rats subjected to chronic social instability stress Nowacka, M.
2015
25 S2 p. S567-
1 p.
artikel
277 P.1.C.019 Influences of sex and estrous cycle on behavioural and neurochemical alterations induced by the neonatal administration of ketamine to rats Borella, V
2015
25 S2 p. S205-S206
2 p.
artikel
278 P.1.c.008 In vivo proton magnetic resonance spectroscopy of the fronto-striatal circuit in paediatric autism spectrum disorder and obsessive compulsive disorder Naaijen, J.
2015
25 S2 p. S198-
1 p.
artikel
279 P.4.c.007 Involvement of dorsal raphe subnuclei in the regulation of anxiety-related defensive behaviour after acute and chronic treatment with imipramine Vilela-Costa, H.H
2015
25 S2 p. S566-S567
2 p.
artikel
280 P.1.c.006 MiRNAs peripheral signature associated with childhood trauma exposure Cattane, N.
2015
25 S2 p. S196-S197
2 p.
artikel
281 P.2.c.007 Neurotrophic mechanisms of candesartan in an animal model of mania induced by D-amphetamine de Souza, G. Coelho
2015
25 S2 p. S409-S410
2 p.
artikel
282 P.6.c.005 New generation of anxiolytics for treatment of opiate-like addiction: advantages and possible clinical application Konstantinopolsky, M.
2015
25 S2 p. S611-S612
2 p.
artikel
283 P.1.c.012 Open-label study comparing the efficacy and tolerability of aripiprazole and risperidone in the treatment of children with autism spectrum disorder and ADHD Lamberti, M.
2015
25 S2 p. S200-S201
2 p.
artikel
284 P.4.c.001 Penile constitutive nitric oxide synthase expression in depressed rats exposed to unpredictable chronic mild stress: role of inflammation Demirtas, T.
2015
25 S2 p. S563-
1 p.
artikel
285 P.1.C.016 Perceived social status mobility relates to perigenual anterior cingulate morphology in individuals with ethnic minority status Capraz, N.
2015
25 S2 p. S203-S204
2 p.
artikel
286 P.1.c.007 Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system Stark, T.
2015
25 S2 p. S197-S198
2 p.
artikel
287 P.1.c.018 Prevalence of gastrointestinal symptoms in young people with autism spectrum disorder Serrano-Drozdowskyj, E.
2015
25 S2 p. S205-
1 p.
artikel
288 P.2.c.004 Safety and tolerability of antipsychotic-mood stabilizer co-treatment in acute bipolar disorder; a systematic review and exploratory meta-analysis Abdelkarim Garcia, M.
2015
25 S2 p. S407-S408
2 p.
artikel
289 P.3.c.002 Selective prolyl oligopeptidase inhibition by IPR19 as a new pharmacological treatment of the cognitive impairment associated with schizophrenia Prades, R.
2015
25 S2 p. S479-S480
2 p.
artikel
290 P.5.c.002 Sphingosine kinase 1 mediated signalling in Parkinson's disease animal model. Neuroprotective effect of fingolimod and a D2/D3 dopamine receptor agonist Moty, J.
2015
25 S2 p. S586-S587
2 p.
artikel
291 P.1.C.017 Stress signature in prenatally stressed rats and in the blood of subjects with childhood trauma history: mRNA-MicroRNA integration approach Cattaneo, A.
2015
25 S2 p. S204-
1 p.
artikel
292 P.3.c.006 Study of the protein expression levels in the pre-frontal cortex of mice subjected to haloperidol chronic exposure Santa, C.
2015
25 S2 p. S481-S482
2 p.
artikel
293 P.2.c.005 The antimanic-like effects of carvone in animal models Andreatini, R.
2015
25 S2 p. S408-
1 p.
artikel
294 P.1.c.014 The effect of predominant polarity on clinical findings and the course of bipolar disorder Coğalmş, F.B.
2015
25 S2 p. S202-
1 p.
artikel
295 P.1.c.011 The modulation of reward-responses is dependent on dopamine D2 receptor activation in the nucleus accumbens Soares-Cunha, C.
2015
25 S2 p. S200-
1 p.
artikel
296 P.1.c.020 The neuro-functional impact of a childhood diagnosis of attention deficit/hyperactivity disorder upon decision making in adulthood McCarthy, H.
2015
25 S2 p. S206-
1 p.
artikel
297 P.3.c.001 The prolyl oligopeptidase inhibitor IPR19 improves cognitive deficits in schizophrenia-like mouse models Munarriz-Cuezva, E.
2015
25 S2 p. S479-
1 p.
artikel
298 P.1.c.009 Trajectories of adolescent conduct problems and cortical thickness: a longitudinal MRI study Oostermeijer, S.
2015
25 S2 p. S199-
1 p.
artikel
299 P.6.c.004 Unveiling metabolic alterations within the human reward circuitry in addiction by using a novel small-voxel, 1H-MRS (spectroscopy) protocol in the nucleus accumbens Engeli, E.J.E.
2015
25 S2 p. S610-S611
2 p.
artikel
300 P.4.c.006 Which brain changes following exposure therapy are associated with long-lasting therapy success? An 8-year follow-up study Lange, I.
2015
25 S2 p. S566-
1 p.
artikel
301 P.2.d.021 Abnormal white matter integrity in bipolar patients and their siblings: a diffusion tensor imaging study Saricicek, A.
2015
25 S2 p. S423-
1 p.
artikel
302 P.3.d.051 A descriptive study of the administration of paliperidone palmitate in a rural area Pablo, R.N. Navarro
2015
25 S2 p. S508-S509
2 p.
artikel
303 P.3.d.085 Aggression and the doses of psychotropic drugs in schizophrenia Knezevic, V.
2015
25 S2 p. S530-
1 p.
artikel
304 P.1.d.003 Alterations of oligodendroglial cells in the rat brain in phencyclidine animal model of schizophrenia: effects of antipsychotic treatment Jevtic, G.
2015
25 S2 p. S207-S208
2 p.
artikel
305 P.2.d.026 A model to uncover bipolarity in recurrent depressive episodes Marinova, P.
2015
25 S2 p. S425-S426
2 p.
artikel
306 P.6.d.005 Anhedonia, depression, anxiety, and craving for opiates in opiate addicts stabilized on oral naltrexone and long acting naltrexone implant Krupitsky, E.
2015
25 S2 p. S614-
1 p.
artikel
307 P.6.d.016 An old chemical that became a new psychoactive substance: study on O-Acetylpsilocin samples handled for analysis and raise of awareness Palma, A.
2015
25 S2 p. S620-S621
2 p.
artikel
308 P.3.d.036 Antipsychotic polypharmacy in schizophrenia: results from a systematic review and meta-analysis of augmentation with a second antipsychotic Galling, B.
2015
25 S2 p. S499-
1 p.
artikel
309 P.3.d.074 Antipsychotic polytherapy and risk of readmission in a mental health hospitalisation unit. A cohort retrospective study Soto Ontoso, M.
2015
25 S2 p. S523-S524
2 p.
artikel
310 P.3.d.031 Antipsychotic treatment in schizophrenia and related psychosis, real life data analysis of oral and long acting antipsychotics Eftekhari, M.
2015
25 S2 p. S496-
1 p.
artikel
311 P.6.d.004 A possible role of cannabis and synthetic cannabimimetics as weight loss agents: preliminary indications Santacroce, R.
2015
25 S2 p. S613-
1 p.
artikel
312 P.3.d.012 A randomized, 13-week study assessing the efficacy and safety of paliperidone palmitate and olanzapine in first-episode schizophrenic patients Manli, H.
2015
25 S2 p. S486-S487
2 p.
artikel
313 P.7.d.009 Are antipsychotics a risk factor for type 2 diabetes in youth? A meta-analysis of incidence rates compared to healthy and psychiatric controls Roldán, A.
2015
25 S2 p. S645-S646
2 p.
artikel
314 P.3.d.035 Aripiprazole in treatment of first episode schizophrenia Kuzmanovic, A.
2015
25 S2 p. S498-S499
2 p.
artikel
315 P.3.d.080 Aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by age: Results from QUALIFY, a head-to-head study Naber, D.
2015
25 S2 p. S527-S528
2 p.
artikel
316 P.3.d.084 Aripiprazole once-monthly is superior to paliperidone palmitate: results from QUALIFY, a randomized, head-to-head clinical study in schizophrenia Potkin, S.G.
2015
25 S2 p. S529-S530
2 p.
artikel
317 P.1.d.002 A role for glial-associated kynurenine pathway activation in modulating neuronal outgrowth and complexity O'Farrell, K.
2015
25 S2 p. S206-S207
2 p.
artikel
318 P.4.d.001 A schedule for tapering out clonazepam in panic disorder patients after long-term treatment Nardi, A.E
2015
25 S2 p. S567-S568
2 p.
artikel
319 P.2.d.013 Asenapine as adjunctive treatment in manic episodes in clinical practice: Results from the MANACOR study Grande, I.
2015
25 S2 p. S418-
1 p.
artikel
320 P.7.d.016 Asperger syndrome in adults and DSM-5: what does the future hold? Signorelli, M.S
2015
25 S2 p. S650-
1 p.
artikel
321 P.7.d.002 A systematic review of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized, controlled trials Maneeton, N.
2015
25 S2 p. S642-
1 p.
artikel
322 P.7.d.001 A systematic review of lisdexamfetamine versus placebo in the treatment of child and adolescent ADHD Maneeton, B.
2015
25 S2 p. S641-S642
2 p.
artikel
323 P.6.d.020 Atomoxetine reduces attentional bias to cocaine-related cues irrespective of norepinephrine transporter gene polymorphism Popham, C.H
2015
25 S2 p. S623-
1 p.
artikel
324 P.6.d.015 A trip to the unknown: 2,5-dimethoxy-4-chloroamphetamine (DOC) sold as LSD: study on samples delivered by users asking for substance analysis Grifell, M.
2015
25 S2 p. S620-
1 p.
artikel
325 P.6.d.003 Baby bonzai: a case of maternal exposure to synthetic cannabinoid during pregnancy Oztürk, Z.
2015
25 S2 p. S612-S613
2 p.
artikel
326 P.6.d.002 Beneficial brain perfusion effect of methadone in opiate addicts Jesic, M. Poznic
2015
25 S2 p. S612-
1 p.
artikel
327 P.2.d.035 Bioequivalence of blood and salivary levels of lithium and valproate: Implications for the clinical management of bipolar disorder Murru, A.
2015
25 S2 p. S429-S430
2 p.
artikel
328 P.1.d.004 Blockade of connexin-43 gap-junctions with the single chain antibody against connexin-43 Leopold, A.
2015
25 S2 p. S208-
1 p.
artikel
329 P.3.d.054 Blonanserin versus aripiprazole for treatment of Japanese schizophrenia patients: a randomized control trial Hori, H.
2015
25 S2 p. S510-S511
2 p.
artikel
330 P.3.d.022 Body mass index, obesity, physical activity level, eating habits and neuroleptics in inpatients with schizophrenia Renemane, L.
2015
25 S2 p. S493-
1 p.
artikel
331 P.3.d.079 Brexpiprazole (OPC-34712) efficacy and safety as maintenance therapy in adults with schizophrenia: Randomised, double-blind, placebo-controlled study Fleischhacker, W.W
2015
25 S2 p. S527-
1 p.
artikel
332 P.3.d.063 Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study Citrome, L.
2015
25 S2 p. S516-S517
2 p.
artikel
333 P.6.d.019 Cannabinoid hyperemesis syndrome; a prevalence study Bruguera, P.
2015
25 S2 p. S622-S623
2 p.
artikel
334 P.3.d.043 Cardiovascular risk factors in outpatients receiving long acting injectable second generation antipsychotics Draghici, A.
2015
25 S2 p. S504-
1 p.
artikel
335 P.3.d.073 Cariprazine and the reduction of hostility associated with schizophrenia Citrome, L.
2015
25 S2 p. S523-
1 p.
artikel
336 P.3.d.053 Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial Debelle, M.
2015
25 S2 p. S510-
1 p.
artikel
337 P.2.d.014 Categorical improvement across mania symptoms: pooled analyses of cariprazine phase II/III trials Durgam, S.
2015
25 S2 p. S418-S419
2 p.
artikel
338 P.3.d.089 Changes in body mass and metabolic profiles over 12 months in patients with first-episode schizophrenia treated with flupenthixol decanoate Chiliza, B.
2015
25 S2 p. S532-S533
2 p.
artikel
339 P.3.d.077 Clinical Global Impression after aripiprazole once-monthly and paliperidone palmitate: Results from QUALIFY, a head-to-head study in schizophrenia Naber, D.
2015
25 S2 p. S525-S526
2 p.
artikel
340 P.3.d.094 Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being Anand, E.
2015
25 S2 p. S535-S536
2 p.
artikel
341 P.2.d.030 Clock genes associate with white matter integrity in depressed bipolar patients: a tract-based spatial statistics study Bollettini, I.
2015
25 S2 p. S427-
1 p.
artikel
342 P.6.d.022 Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use: mutual effects of an unholy alliance Wunderli, M.
2015
25 S2 p. S624-S625
2 p.
artikel
343 P.6.d.023 Co-localised structural and functional changes in cocaine users are associated with recent cocaine consumption and potentially reversible Herdener, M.
2015
25 S2 p. S625-
1 p.
artikel
344 P.4.d.005 Combining clomipramine and paroxetine for treatment-resistant obsessive compulsive disorder Amodeo, G.
2015
25 S2 p. S569-S570
2 p.
artikel
345 P.3.d.060 Comparative clinical outcomes of orodispersable versus standard oral olanzapine tablets in non-adherent patients with schizophrenia or bipolar disorder Novick, D.
2015
25 S2 p. S514-S515
2 p.
artikel
346 P.2.d.005 Correlation between kidney function and ultrasonographic findings in bipolar patients receiving long-term lithium treatment Abramowicz, M.
2015
25 S2 p. S413-
1 p.
artikel
347 P.2.d.001 Cortisol levels in nails and neurocognitive performance in euthymic bipolar I patients and healthy controls Herane, A.
2015
25 S2 p. S410-S411
2 p.
artikel
348 P.2.d.009 Cyamemazine and pancytopenia in a bipolar patient with psychosomatic complaints Da Ponte, G.
2015
25 S2 p. S415-S416
2 p.
artikel
349 P6.d.018 Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) alone and in combination affect brain activity during rest Van Hell, H.H
2015
25 S2 p. S621-S622
2 p.
artikel
350 P.3.d.056 Deltoid injection of aripiprazole once-monthly in the treatment of schizophrenia Peters-Strickland, T.
2015
25 S2 p. S511-S512
2 p.
artikel
351 P.3.d.045 Does clozapine treatment modify ‘jumping to conclusions’? Molins, C.
2015
25 S2 p. S505-
1 p.
artikel
352 P.3.d.070 Drug adherence issues in schizophrenia–different views between psychiatrists and case managers in Hong Kong Chung, W.D.
2015
25 S2 p. S521-
1 p.
artikel
353 P.3.d.055 Drug induced obesity in schizophrenia: A chart review Tominaga, H.
2015
25 S2 p. S511-
1 p.
artikel
354 P.3.d.010 Effectiveness, tolerability and treatment adherence of high doses of paliperidone palmitate in patients with severe schizophrenia Fernandez-Miranda, J.J.
2015
25 S2 p. S485-S486
2 p.
artikel
355 P.3.d.049 Effects of antipsychotic switch on body weight, blood data, and vital signs in patients with acute-phase schizophrenia: a retrospective study Igata, R.
2015
25 S2 p. S507-S508
2 p.
artikel
356 P.7.d.003 Effects of glutamatergic agents in the treatment of compulsivity and impulsivity in child and adolescent psychiatry: a systematic review Mechler, K.
2015
25 S2 p. S643-
1 p.
artikel
357 P.7.d.005 Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project Carucci, S.
2015
25 S2 p. S644-
1 p.
artikel
358 P.2.d.023 Effects of the interaction between lithium and glycogen synthase kinase 3 in effective connectivity on neural response to emotional processing in bipolar disorder Bulgarelli, C.
2015
25 S2 p. S424-S425
2 p.
artikel
359 P.3.d.018 Efficacy and safety of aripiprazole and haloperidol in patients with schizophrenia Sulejmanpasic-Arslanagic, G.
2015
25 S2 p. S490-S491
2 p.
artikel
360 P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies Correli, C.
2015
25 S2 p. S522-S523
2 p.
artikel
361 P.3.d.041 Efficacy and safety of extended-release paliperidone in patients at high risk of drug-drug interaction Guillena, S.L. Romero
2015
25 S2 p. S502-S503
2 p.
artikel
362 P.7.d.004 Efficacy and safety of fluoxetine in the treatment of posttraumatic stress disorder in children and adolescents Martsenkovskyi, D.
2015
25 S2 p. S643-S644
2 p.
artikel
363 P.3.d.046 Efficacy and tolerability of paliperidone palmitate in schizophrenics with comorbid drug use. A comparative study Dominguez, L.A. Nunez
2015
25 S2 p. S506-
1 p.
artikel
364 P.3.d.058 Efficacy, safety and tolerability of aripirazole–clozapine combination therapy Bise, S.
2015
25 S2 p. S513-
1 p.
artikel
365 P.2.d.028 Emotion dysregulation and bipolar I disorder Yasmine, L.
2015
25 S2 p. S426-S427
2 p.
artikel
366 P.3.d.082 Enhancing cognitive remediation therapy with transcranial direct current stimulation: preliminary findings in schizophrenia Pigoni, A.
2015
25 S2 p. S528-S529
2 p.
artikel
367 P.2.d.020 Enlarged inferior frontal gyrus volume might be a structural endophenotype for bipolar disorder: A voxel-based morphometry study Saricicek, A.
2015
25 S2 p. S422-S423
2 p.
artikel
368 P.3.d.004 Factors of medication non adherence in schizophrenia Hajji, K.
2015
25 S2 p. S483-
1 p.
artikel
369 P.6.d.011 Frequency and factors associated with depression in subjects with tramadol abuse Rizk, M.M
2015
25 S2 p. S617-
1 p.
artikel
370 P.3.d.034 Frequency of antipsychotic polypharmacy in schizophrenic outpatients Akkisi Kumsar, N.
2015
25 S2 p. S498-
1 p.
artikel
371 P.6.d.008 Functional connectivity patterns between putamen and anterior cingulate cortex during response inhibition in smokers and non-smokers Akkermans, S.
2015
25 S2 p. S615-
1 p.
artikel
372 P.2.d.019 Functioning, theory of mind, and cognitive dysfunction in bipolar disorder Guillena, S.L. Romero
2015
25 S2 p. S421-S422
2 p.
artikel
373 P.4.d.008 Gender differences in benzodiazepines prescription in old age patients Martinez-Cengotitabengoa, M.
2015
25 S2 p. S571-S572
2 p.
artikel
374 P.1.d.005 Glial plasticity as a key mechanism underlying the pathophysiology of depression Machado-Santos, A.R.
2015
25 S2 p. S208-S209
2 p.
artikel
375 P.7.d.014 Guanfacine extended release: daytime sleepiness outcomes from a phase 3 clinical study in adolescents with attention-deficit/hyperactivity disorder Cutler, A.
2015
25 S2 p. S648-S649
2 p.
artikel
376 P.3.d.069 How many patients with schizophrenia do not respond to antipsychotic drugs? Samara, M.
2015
25 S2 p. S520-S521
2 p.
artikel
377 P.2.d.034 How to improve bipolar disorder management? A novel prospective: the use of biomarkers Marsano, A.
2015
25 S2 p. S429-
1 p.
artikel
378 P.6.d.021 Impact of co-occurring cannabis and tobacco use in patients with severe mental disorder Berta, S.
2015
25 S2 p. S624-
1 p.
artikel
379 P.3.d.092 Impact on hospitalisation of long acting injectable paliperidone in a first episode sample (Lehenak program) Gil, P.
2015
25 S2 p. S534-S535
2 p.
artikel
380 P.5.d.007 Improved spatial memory under dopaminergic medication in Parkinson's disease patients with subclinical depressive symptoms Stankevich, Y.
2015
25 S2 p. S590-S591
2 p.
artikel
381 P.2.d.011 Increased mean platelet volume in patients with bipolar disorder in manic and euthymic states Cansiz, A.
2015
25 S2 p. S416-S417
2 p.
artikel
382 P.2.d.004 Influence of body mass index on quality of life in patients with bipolar disorder Jang, S.H.
2015
25 S2 p. S412-S413
2 p.
artikel
383 P.3.d.093 Inhaled loxapine as an effective alternative treatment in acute psychiatric agitation Iza, M.
2015
25 S2 p. S535-
1 p.
artikel
384 P.2.d.031 Integrated mania management: an observational study at the rehabilitative mood disorder unit of San Raffaele hospital in Milan Brioschi, S.
2015
25 S2 p. S427-S428
2 p.
artikel
385 P.3.d.028 Interventions that may reduce the re-hospitalisation risk of patients with schizophrenia spectrum disorders Videnova, V.
2015
25 S2 p. S495-
1 p.
artikel
386 P.6.d.014 Investigating ‘waiting impulsivity’ in cocaine addiction: are the effects of atomoxetine mediated by genotype? Pollard, M.I
2015
25 S2 p. S619-
1 p.
artikel
387 P.6.d.017 Is this really ketamine? The presence of methoxetamine on drug samples delivered as ketamine for substance analysis Quintana, P.
2015
25 S2 p. S621-
1 p.
artikel
388 P.6.d.006 I was gonna process rewards – but then I got high: the acute and chronic effects of cannabis and ketamine on reward processing Lawn, W.
2015
25 S2 p. S614-S615
2 p.
artikel
389 P.3.d.007 Leukocytosis in clozapine-treated patients: a sign of loss of response to the antipsychotic Prisco, V.
2015
25 S2 p. S484-
1 p.
artikel
390 P.3.d.067 Long-acting injectable vs oral antipsychotics for hospitalisation prevention in schizophrenia: a systematic review/meta-analysis of cohort studies Kishimoto, T.
2015
25 S2 p. S519-
1 p.
artikel
391 P.3.d.057 Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial Durgam, S.
2015
25 S2 p. S512-S513
2 p.
artikel
392 P.7.d.013 Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder Zuddas, A.
2015
25 S2 p. S648-
1 p.
artikel
393 P.2.d.016 Lurasidone for older adults with bipolar depression: analysis of two double-blind, placebo-controlled studies Sajatovic, M.
2015
25 S2 p. S420-
1 p.
artikel
394 P.2.d.017 Lurasidone in the long-term treatment of patients with bipolar i disorder: responder and remitter status during a 24-week open-label extension study Ketter, T.
2015
25 S2 p. S420-S421
2 p.
artikel
395 P.3.d.065 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale Loebel, A.
2015
25 S2 p. S518-
1 p.
artikel
396 P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale Loebel, A.
2015
25 S2 p. S491-
1 p.
artikel
397 P.3.d.064 May genetic variation in multi-drug resistance 1 gene influence psychotic and functional improvement in schizophrenia and related disorders patients? Catalán, R.
2015
25 S2 p. S517-
1 p.
artikel
398 P.2.d.022 Mental disorders in offspring of parents with bipolar disorder Cho, Y.-S.
2015
25 S2 p. S423-S424
2 p.
artikel
399 P.3.d.047 Metabolic syndrome and functionality 2-year follow-up study of 33 outpatients with a mental disorder treatment with paliperidone palmitate Zarranz, I.
2015
25 S2 p. S506-S507
2 p.
artikel
400 P.3.d.083 Naturalistic observational clinical experience of inhalable loxapine as acute treatment of agitation Karlsson, P.
2015
25 S2 p. S529-
1 p.
artikel
401 P.5.d.001 Neuropsychiatric assessment in patients with amyotrophic lateral sclerosis Guillena, S.L. Romero
2015
25 S2 p. S587-
1 p.
artikel
402 P.5.d.006 Neurosyphilis presenting with psychosis and dementia – a case report Sirin, P.S.
2015
25 S2 p. S589-S590
2 p.
artikel
403 P.2.d.010 Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder Kalelioglu, T.
2015
25 S2 p. S416-
1 p.
artikel
404 P.3.d.008 Nor-clozapine plasma concentration/daily clozapine dose ratio: an index of response to clozapine treatment Prisco, V.
2015
25 S2 p. S484-S485
2 p.
artikel
405 P.4.d.007 Olanzapine augmentation in alleviating treatment-resistant nightmares and insomnia in patients with combat-related PTSD Sulejmanpasic-Arslanagic, G.
2015
25 S2 p. S570-S571
2 p.
artikel
406 P.3.d.075 Once-monthly paliperidone palmitate compared with oral conventional or oral atypical antipsychotic treatment in patients with schizophrenia Alphs, L.
2015
25 S2 p. S524-S525
2 p.
artikel
407 P.3.d.037 Optimising response to lurasidone in patients with acute schizophrenia: A randomised, double-blind, placebo-controlled study of dosing regimens Loebel, A.
2015
25 S2 p. S500-
1 p.
artikel
408 P.3.d.076 Paliperidone “long-acting” and plasma levels along 1 year of maintenance therapy in schizophrenia and schizoaffective disorder Di Pace, C.
2015
25 S2 p. S525-
1 p.
artikel
409 P.3.d.052 Paliperidone palmitate effects on the electrocardiogram in Japanese patients with schizophrenia Sunada, N.
2015
25 S2 p. S509-S510
2 p.
artikel
410 P.3.d.062 Paliperidone palmitate: evaluation of effectiveness using a mirror image study Mata Iturralde, L.
2015
25 S2 p. S515-S516
2 p.
artikel
411 P.3.d.040 Paliperidone palmitate versus conventional depots and oral antipsychotics in inpatients with schizophrenia Guillena, S.L. Romero
2015
25 S2 p. S501-S502
2 p.
artikel
412 P.3.d.086 Patterns of antipsychotics prescription in a psychiatric ward in Lisbon – a cross-sectional study Duarte, M.
2015
25 S2 p. S531-
1 p.
artikel
413 P.3.d.061 Pharmacological approach and social functioning in schizophrenic outpatients Pirlog, M.C
2015
25 S2 p. S515-
1 p.
artikel
414 P.3.d.059 Plasma levels of second generation antipsychotics as indicators of clinical response and severity of side-effects in first-episode psychosis patients Bustillo, M.
2015
25 S2 p. S513-S514
2 p.
artikel
415 P.2.d.008 Polarity index of maintenance treatment for bipolar disorder and mixed depression: associations with temperament profile in a naturalistic setting Ferentinos, P.
2015
25 S2 p. S415-
1 p.
artikel
416 P.6.d.009 Polyabuse and diversion of drugs: methylphenidate/cannabis-induced manic like-symptoms Cinosi, E.
2015
25 S2 p. S615-S616
2 p.
artikel
417 P.3.d.068 Polymorphism of DISC1 and GAD2 genes: genetic markers of risk for schizophrenia and pharmacogenetic markers of haloperidol efficiency Kinyasheva, K.O.
2015
25 S2 p. S520-
1 p.
artikel
418 P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease Ivanova, S.A
2015
25 S2 p. S589-
1 p.
artikel
419 P.2.d.007 Postpartum relapse risk in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis Wesseloo, R.
2015
25 S2 p. S414-
1 p.
artikel
420 P.2.d.027 Post-traumatic growth in caregivers of bipolar affective disorder patients and related factors Eradamlar, N.
2015
25 S2 p. S426-
1 p.
artikel
421 P.3.d.091 Prediction of response to antipsychotic drugs in the early phase of schizophrenia Yildiz, M.
2015
25 S2 p. S534-
1 p.
artikel
422 P.3.d.017 Prevalence and predictors of the metabolic syndrome in patients on the long term atypical antipsychotic treatment Popovic, I.
2015
25 S2 p. S490-
1 p.
artikel
423 P.5.d.004 Psychiatric comorbidity in elderly patients with vascular cognitive disorder Arnaoudova, M.
2015
25 S2 p. S588-S589
2 p.
artikel
424 P.3.d.021 Psychopharmacologic treatment in bipolar, schizoaffective and schizophrenic patients: a descriptive study Moreno Monmany, J.
2015
25 S2 p. S492-S493
2 p.
artikel
425 P.3.d.066 QTc prolongation and antipsychotics: a connection to remember Sousa, A.
2015
25 S2 p. S518-S519
2 p.
artikel
426 P.7.d.010 Randomised placebo-controlled study of polyunsaturated omega-3 fatty acids as an add-on treatment in adolescent anorexia nervosa Pirog-Balcerzak, A.
2015
25 S2 p. S646-
1 p.
artikel
427 P.3.d.020 Recovery in bipolar depression: analysis of a 6-week, placebo-controlled lurasidone trial followed by a 6-month continuation study Siu, C.
2015
25 S2 p. S492-
1 p.
artikel
428 P.3.d.078 Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: Results from QUALIFY, a head-to-head study in schizophrenia G. Potkin, S.
2015
25 S2 p. S526-
1 p.
artikel
429 P.3.d.050 Reduction of hospital admissions in patients treated with palmitate of paliperidone (PP) Lopez Velasco, R.
2015
25 S2 p. S508-
1 p.
artikel
430 P.3.d.088 Regional variation in data analytic findings in global schizophrenia clinical trials Daniel, D.
2015
25 S2 p. S532-
1 p.
artikel
431 P.3.d.048 Relationship between insight, treatment adherence, socio-demographic and clinical variables in outpatients with schizophrenia Fernández-Quintana, A.
2015
25 S2 p. S507-
1 p.
artikel
432 P.5.d.003 Relationship between psychiatric and neurological diagnosis in patients presenting to an outpatient neurology service with cognitive complaints Guillena, S.L. Romero
2015
25 S2 p. S587-S588
2 p.
artikel
433 P.3.d.025 Relationship between treatment compliance, insight and hospitalisations among schizophrenia patients Sarikaya Varlik, D.
2015
25 S2 p. S493-S494
2 p.
artikel
434 P.7.d.012 Relative efficacy of lisdexamfetamine dimesylate and osmotic controlled-release methylphenidate in attention-deficit/hyperactivity disorder patients Coghill, D.R.
2015
25 S2 p. S647-S648
2 p.
artikel
435 P.3.d.014 Reliability of subjective clinical prognosis in first-episode schizophrenia patients – data from the EUFEST study Matei, V.
2015
25 S2 p. S488-
1 p.
artikel
436 P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder Del Valle Rubido, M.
2015
25 S2 p. S646-S647
2 p.
artikel
437 P.6.d.024 Reviewing “apinaca”, an emergent synthetic cannabinoid receptor agonist Dinamarca, F.
2015
25 S2 p. S626-
1 p.
artikel
438 P.7.d.015 Risperidone and atomoxetine in the treatment of severe and challenging behaviours in children with pervasive developmental disorders Martsenkovska, I.
2015
25 S2 p. S649-
1 p.
artikel
439 P.2.d.033 Role of cortical thickness as an endophenotype for bipolar disorder: a vertex-wise analysis in bipolar disorder patients and first degree relatives Yalin, N.
2015
25 S2 p. S428-S429
2 p.
artikel
440 P.2.d.002 Seasonal pattern of manic episode admissions among bipolar I disorder patients is associated with male gender and higher rates of psychotic features Hochman, E.
2015
25 S2 p. S411-
1 p.
artikel
441 P.3.d.044 Self-reported antipsychotic adherence among outpatients with a severe mental disorder: a comparative study González-Blanco, L.
2015
25 S2 p. S504-S505
2 p.
artikel
442 P.6.d.013 Self-reported impulsivity and gambling decision-making but not delay discounting covary with changing cocaine use across one year Hulka, L.
2015
25 S2 p. S618-S619
2 p.
artikel
443 P.4.d.006 Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial Costa, D.L.C.
2015
25 S2 p. S570-
1 p.
artikel
444 P.2.d.015 Short telomeres in subjects with remitted bipolar disorder Adriane, R.
2015
25 S2 p. S419-S420
2 p.
artikel
445 P.3.d.029 Sodium nitroprusside in treatment-refractory schizophrenia: a case-report Froelich, F.
2015
25 S2 p. S495-S496
2 p.
artikel
446 P.3.d.032 Study of efficiency and tolerance after changing from olanzapine and risperidone to oral paliperidone in a sample of patients with schizophrenia Torrecilla Olavarrieta, R.
2015
25 S2 p. S496-S497
2 p.
artikel
447 P.3.d.033 Study of efficiency, physical health and tolerance of paliperidone palmitate in patients with severe mental disorder Torrecilla, R.
2015
25 S2 p. S497-S498
2 p.
artikel
448 P.2.d.003 Suicidal behaviour in major depressive episode: evidence from the BRIDGE-II-MIX study Popovic, D.
2015
25 S2 p. S412-
1 p.
artikel
449 P.3.d.015 Supported employment program in first episode psychosis: clinical outcome improvements at 1 year follow up Toll Privat, A.
2015
25 S2 p. S488-S489
2 p.
artikel
450 P.2.d.037 Telemedicine in bipolar disorder García-Alocén, A.
2015
25 S2 p. S430-S431
2 p.
artikel
451 P.6.d.010 The 2D:4D digit ratio as biomarker for substance abuse Fernstrand, A.M
2015
25 S2 p. S616-S617
2 p.
artikel
452 P.3.d.090 The effectiveness of art therapy in the rehabilitation of patients with schizophrenia Kryshtal, O.
2015
25 S2 p. S533-
1 p.
artikel
453 P.3.d.071 The effect of brexpiprazole (OPC-34712) in adult outpatients with early-episode schizophrenia: An exploratory study Weiss, C.
2015
25 S2 p. S521-S522
2 p.
artikel
454 P.3.d.038 The effects of risperidone long-acting injection versus paliperidone palmitate on cognitive and social function in schizophrenia – an open pilot randomised controlled trial Koshikawa, Y.
2015
25 S2 p. S500-S501
2 p.
artikel
455 P.7.d.008 The impact of sleep on inattention, impulsiveness and cognitive failures Voinescu, B.I.
2015
25 S2 p. S644-S645
2 p.
artikel
456 P.4.d.004 The influence of baseline severity on antidepressant efficacy for anxiety disorders: a meta-analysis and meta-regression De Vries, Y.A
2015
25 S2 p. S568-S569
2 p.
artikel
457 P.3.d.005 The preference survey for long-acting injectable antipsychotics of community-dwelling patients with schizophrenia and their caregivers Choi, Y.S
2015
25 S2 p. S483-S484
2 p.
artikel
458 P.3.d.027 The risk for readmission in schizophrenia patients treated with long-acting injectable (typical or atypical) versus oral antipsychotics Onn, R.
2015
25 S2 p. S494-
1 p.
artikel
459 P.3.d.002 The role of electroconvulsive therapy in the treatment of schizophrenia Hajji, K.
2015
25 S2 p. S482-S483
2 p.
artikel
460 P.2.d.006 The validity of the modified Korean version of the mood disorder questionnaire Jon, D.
2015
25 S2 p. S413-S414
2 p.
artikel
461 P.2.d.018 The value of early improvement as a predictor of short-term response during treatment of bipolar depression with lurasidone Iosifescu, D.V
2015
25 S2 p. S421-
1 p.
artikel
462 P.3.d.087 Tobacco smoking in patients taking antipsychotic long-acting injections and sexual dysfunction Ribeiro, H. Prata
2015
25 S2 p. S531-S532
2 p.
artikel
463 P.3.d.042 Treatment discontinuation in schizophrenia. Paliperidone palmitate versus oral antipsychotics Guillena, S.L. Romero
2015
25 S2 p. S503-S504
2 p.
artikel
464 P.4.d.003 Treatment-related functional orbitofrontal network alterations in veterans with posttraumatic stress disorder Kennis, M.
2015
25 S2 p. S568-
1 p.
artikel
465 P.3.d.001 Treatment with antipsychotics in inpatients psychiatric units Alvarez-Garcia, R.
2015
25 S2 p. S482-
1 p.
artikel
466 P.3.d.016 Two-year effectiveness of maintenance treatment with risperidone or olanzapine after discharge in patients with schizophrenia Yoshimura, Y.
2015
25 S2 p. S489-
1 p.
artikel
467 P.2.d.012 Unrecognised bipolar spectrum disorder in elderly patients with recurrent depression Jung, Y.
2015
25 S2 p. S417-
1 p.
artikel
468 P.6.d.012 Use of other substances among kratom users: findings from a 2011 national household survey in Thailand Likhitsathian, S.
2015
25 S2 p. S617-S618
2 p.
artikel
469 P.3.d.039 Use of paliperidone palmitate in clinical practice: a 36-month follow-up study. From effectiveness to functional recovery Guillena, S.L. Romero
2015
25 S2 p. S501-
1 p.
artikel
470 P.3.d.011 Vascular endothelial growth factor may have a neuroprotective role in the improvement of schizophrenia or in the treatment effects of antipsychotics Kim, Y.K.
2015
25 S2 p. S486-
1 p.
artikel
471 P.3.d.013 Weight gain and antipsychotics, data from EUFEST study Matei, V.
2015
25 S2 p. S487-S488
2 p.
artikel
472 P.2.d.025 White matter microstructure in bipolar disorder changes after antidepressant treatment with total sleep deprivation Poletti, S.
2015
25 S2 p. S425-
1 p.
artikel
473 P1.e.002 Activation of the brain serotonergic system decreases the expression and activity of liver cytochrome P450 isoforms CYP1A, 2C11 and 3A Rysz, M.
2015
25 S2 p. S209-S210
2 p.
artikel
474 P.1.e.017 A decrease in phosphorylation of CREB may explain delayed place learning and attenuated long-term potentiation in adult-onset hyperthyroidism Süer, C.
2015
25 S2 p. S218-S219
2 p.
artikel
475 P.1.e.020 Adult onset hyperthyroidism enhances LTD and up-regulates p38-MAPK and PP1 expression in rat hippocampus Yousef, M.
2015
25 S2 p. S220-S221
2 p.
artikel
476 P.1.e.025 Alterations of serum brain-derived neurotrophic factor levels and its effects on cognitive functions during early and late alcohol withdrawal Besirli, A.
2015
25 S2 p. S223-S224
2 p.
artikel
477 P.1.e.024 AMP-activated protein kinase is implicated in depressive behaviour Cordero, M.D.
2015
25 S2 p. S223-
1 p.
artikel
478 P.2.e.007 Antipsychotic drugs in depression: the unexplored role of neuroplasticity Morais, M.
2015
25 S2 p. S433-S434
2 p.
artikel
479 P.2.e.002 A specific multispecies probiotic product can reduce depressive symptoms Van Hemert, S.
2015
25 S2 p. S432-
1 p.
artikel
480 P.3.e.002 Caregiver burden associated with providing care for adults with schizophrenia in France Gupta, S.
2015
25 S2 p. S536-
1 p.
artikel
481 P.1.e.008 Cortisol and postpartum mental health Milosavljevic, M.
2015
25 S2 p. S213-S214
2 p.
artikel
482 P.1.e.016 Dexamethasone plasma levels impact glucocorticoid receptors-challenge tests for detection of HPA-axis alterations Menke, A.
2015
25 S2 p. S218-
1 p.
artikel
483 P.2.e.001 Differentiated antidepressant-like profiles of ketamine, fluoxetine and vortioxetine in Flinders Sensitive Line (FSL) rats depleted of endogenous 5-HT Du Jardin, K.G
2015
25 S2 p. S431-
1 p.
artikel
484 P.2.e.003 Effect of acute administration of agomelatine on the memory processes triggered by threat responses to an auditory stimulus in rats Gabriel Gracia, C.
2015
25 S2 p. S432-S433
2 p.
artikel
485 P.4.e.001 Effect of resveratrol on penile neuronal and endothelial nitric oxide synthase expression in chronic unpredictable mild stress depression model Yazir, Y.
2015
25 S2 p. S572-
1 p.
artikel
486 P.5.e.001 Effects of etanercept on vascular dementia in aged rats Utkan, T.
2015
25 S2 p. S591-
1 p.
artikel
487 P.1.e.007 Emotion recognition during cocaine intoxication Kuypers, K.
2015
25 S2 p. S213-
1 p.
artikel
488 P.6.e.003 Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge eating Di Bonaventura, M.V. Micioni
2015
25 S2 p. S627-S628
2 p.
artikel
489 P.1.e.003 Evaluation of cognitive function and brain-derived neurotrophic factor (BDNF) levels in a sample of euthymic bipolar patients Piccinni, A.
2015
25 S2 p. S210-S211
2 p.
artikel
490 P.1.e.019 Favoring long-term depression over long-term potentiation in adult-onset hypothyroidism is prevented by dietary selenium supplementation Bayar, Y.
2015
25 S2 p. S220-
1 p.
artikel
491 P.1.e.023 Functional mutations in CADPS identified in patients with early-onset bipolar disorder Sitbon, J.
2015
25 S2 p. S222-S223
2 p.
artikel
492 P.1.e.021 Glucocorticoid receptor and glucocorticoid receptor-target genes: modulation in response to stressful life events Lopizzo, N.
2015
25 S2 p. S221-
1 p.
artikel
493 P.1.e.014 Hypoactive sexual desire disorder in women: the role of testosterone Marques, S.
2015
25 S2 p. S217-
1 p.
artikel
494 P.1.e.006 Interplay between stress hormone responses and impaired reward learning ability in major depressive disorder: a longitudinal study Vrieze, E.
2015
25 S2 p. S212-S213
2 p.
artikel
495 P.1.e.004 Lack of specific association between panicogenic properties of caffeine and HPA-axis activation in panic disorder: a placebo-controlled study Masdrakis, V
2015
25 S2 p. S211-
1 p.
artikel
496 P.1.e.018 Maternal l-thyroxine treatment during lactation affects learning and anxiety-like behaviours but not spatial memory in adult rat progeny Tan, B.
2015
25 S2 p. S219-S220
2 p.
artikel
497 P.1.e.009 Neurocognitive and neurochemical responses in patients with anxiety and allostatic load: beyond anxiolysis, can cognition be improved by alprazolam? D'Alessio, L.
2015
25 S2 p. S214-S215
2 p.
artikel
498 P.1.e.015 Neuronal plasticity of language-related brain regions induced by long-term testosterone treatment Hahn, A.
2015
25 S2 p. S217-S218
2 p.
artikel
499 P.1.e.001 Plasma oxytocin in adult OCD patients Marazziti, D.
2015
25 S2 p. S209-
1 p.
artikel
500 P.1.e.013 Pregnancy, anxiety symptoms and catecholaminergic genotype are associated with prepulse inhibition of the startle response in women Comasco, E.
2015
25 S2 p. S216-
1 p.
artikel
501 P.6.e.002 Problematic internet use in the general population: results from an internet-based survey Van Ameringen, M.
2015
25 S2 p. S627-
1 p.
artikel
502 P.1.e.026 Relationship between dehydroepiandrosterone sulfate (DHEA-s) levels and severity in patients with major depressive disorder Kim, S.H.
2015
25 S2 p. S224-S225
2 p.
artikel
503 P.1.e.012 Relationship between the level of hormones and cognitive abilities of male schizophrenia patients – preliminary results Bratek, A.
2015
25 S2 p. S215-S216
2 p.
artikel
504 P.1.e.005 Repeated stress hormone measurements after a social stressor in major depressive disorder: association patterns and predictive ability Vrieze, E.
2015
25 S2 p. S211-S212
2 p.
artikel
505 P.4.e.003 Social conditioning of neutral faces: A pilot-study on brain functioning in social anxiety patients and their unaffected first-degree relatives Bas-Hoogendam, J.M.
2015
25 S2 p. S573-S574
2 p.
artikel
506 P.2.e.004 Sub-chronic vortioxetine treatment – but not escitalopram – enhances pyramidal neuron activity in the rat prefrontal cortex Riga, M.S.
2015
25 S2 p. S433-
1 p.
artikel
507 P.1.e.022 The influence of cross-sex hormone therapy in transgender persons on neural correlates of empathy Spies, M.
2015
25 S2 p. S221-S222
2 p.
artikel
508 P.4.e.002 Traumatic brain injury induces post-traumatic stress disorder-like behaviors in mice: possible role of white matter alterations Mongeau, R.
2015
25 S2 p. S572-S573
2 p.
artikel
509 P.1.e.010 Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression Veen, C.
2015
25 S2 p. S215-
1 p.
artikel
510 P.6.e.001 When motivation becomes maladaptive – similarities between drug addiction and obesity Kupchik, Y.M
2015
25 S2 p. S626-S627
2 p.
artikel
511 P.2.f.009 A comparative prospective study of agomelatine versus escitalopram in treatment of severe major depressive disorder Petrescu, B.
2015
25 S2 p. S439-
1 p.
artikel
512 P.2.f.024 Adequacy of antidepressant treatment in primary care: preliminary results after implementing a computerised guide for major depression Cavero, M.
2015
25 S2 p. S448-
1 p.
artikel
513 P.2.f.026 Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study Baker, R.
2015
25 S2 p. S449-
1 p.
artikel
514 P.2.f.008 Aerobic exercise as add-on treatment improves alertness in depressed inpatients: preliminary results from a randomised controlled multicentre-trial Imboden, C.
2015
25 S2 p. S438-
1 p.
artikel
515 P.4.f.003 A factorial analysis of the dynamics of different types of obsessions due to brain damage Margaryan, S.
2015
25 S2 p. S575-
1 p.
artikel
516 P.1.f.003 An immunologic profile study in drug-näive generalized anxiety non depressed patients: a pilot study Tofani, T.
2015
25 S2 p. S226-
1 p.
artikel
517 P.2.f.028 Antidepressant efficacy of S-adenosyl-L-methionine in major depressive disorder Orsolini, L.
2015
25 S2 p. S450-S451
2 p.
artikel
518 P.1.f.001 Anti-NMDA receptor autoimmune encephalitis in psychiatric practice Kevere, L.
2015
25 S2 p. S225-
1 p.
artikel
519 P.3.f.010 A paradigm shift in the administration of long-acting injectable antipsychotics in a rural area. The role of geographic dispersion Santamaria, O.
2015
25 S2 p. S541-
1 p.
artikel
520 P.2.f.013 A precision medicine approach to antidepressant treatment in depression Dawson, G.R
2015
25 S2 p. S441-
1 p.
artikel
521 P.6.f.010 Assessing for food addiction in an obese Chilean population seeking for bariatric surgery Gabler, G.
2015
25 S2 p. S633-
1 p.
artikel
522 P.1.f.020 Association between peripheral interleukin 6 and brain response to positive stimuli in a depressive spectrum Costi, S.
2015
25 S2 p. S235-S236
2 p.
artikel
523 P.1.f.012 Association of psychiatric disorders and diseases affecting the immune system Larsen, J. Haugen
2015
25 S2 p. S231-S232
2 p.
artikel
524 P.5.f.006 Association of sarcopenia and cognitive impairment among older people in Korea Hee, L. Jin
2015
25 S2 p. S594-
1 p.
artikel
525 P3.f.021 Baseline cardiometabolic risk in a cohort of first-episode schizophrenia patients Misiak, B.
2015
25 S2 p. S547-S548
2 p.
artikel
526 P.4.f.005 BDNF transcripts modulation in the blood of subjects exposed to childhood trauma history Begni, V
2015
25 S2 p. S576-S577
2 p.
artikel
527 P.3.f.015 Behavioural phenotypes in patients with schizophrenia comorbid with obsessive-compulsive disorder Manea, M.
2015
25 S2 p. S544-
1 p.
artikel
528 P.3.f.023 Brief cognitive battery to monitor stable outpatients with schizophrenia Domingo, S. Zaragoza
2015
25 S2 p. S549-
1 p.
artikel
529 P.1.f.002 Caffeine affects cytokine secretion after immunity stimulation by Freund's complete adjuvant Pohanka, M.
2015
25 S2 p. S225-S226
2 p.
artikel
530 P.6.f.008 Cannabis use among patients hospitalised in Tunisian psychiatric department Hajji, K.
2015
25 S2 p. S632-
1 p.
artikel
531 P.4.f.001 Childhood traumatic events and trauma: an observational study Sarchione, F.
2015
25 S2 p. S574-
1 p.
artikel
532 P.2.f.004 Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression Grosse, L.
2015
25 S2 p. S435-S436
2 p.
artikel
533 P.5.f.007 Comorbidity and polypharmacy in residential care and community-dwelling elderly in Portugal Ferreira, A.R.
2015
25 S2 p. S595-
1 p.
artikel
534 P.2.f.007 Comparison of aripiprazole versus bupropion augmentation for treatment of older patients with MDD: a randomized prospective open-label multi-center study Kim, H.G
2015
25 S2 p. S437-S438
2 p.
artikel
535 P.6.f.012 Correlation between depression and thyroid function disturbance in women opiate addicts Brkovic, J. Kavaric
2015
25 S2 p. S633-S634
2 p.
artikel
536 P.2.f.003 Correlation between thyroid disease and depressive symptoms Alimanovic-Alagic, R.
2015
25 S2 p. S435-
1 p.
artikel
537 P.1.f.006 Cytokine concentrations after heavy alcohol consumption in people with and without a hangover Raasveld, S.J.
2015
25 S2 p. S228-
1 p.
artikel
538 P.1.f.005 Cytokines and mood in healthy young adults Jansen, J.
2015
25 S2 p. S227-S228
2 p.
artikel
539 P.3.f.017 Depersonalization and schizophrenia Moreno, M.J. Jaen
2015
25 S2 p. S545-
1 p.
artikel
540 P.2.f.012 Depression in multiple sclerosis focusing on treatment possibilities Hegedus, K.
2015
25 S2 p. S440-S441
2 p.
artikel
541 P.3.f.005 Depressive symptoms in patients with schizophrenia Aladashvili, T.
2015
25 S2 p. S538-S539
2 p.
artikel
542 P.1.f.007 Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease Hyun, K.
2015
25 S2 p. S228-S229
2 p.
artikel
543 P.5.f.003 Differential response style on the personality assessment inventory according to compensation-seeking status in patients with traumatic brain injury Lee, S.Y.
2015
25 S2 p. S593-
1 p.
artikel
544 P.3.f.022 Discharge and beyond – what happens after discharge of a psychiatric ward for first psychotic episode Agostinho, C.
2015
25 S2 p. S548-
1 p.
artikel
545 P.3.f.027 Duration of untreated psychosis in Tunisian patients: determinants and impact Rebhi, H.
2015
25 S2 p. S551-
1 p.
artikel
546 P.3.f.011 Effectiveness of audiovisual campaigns against the stigmatisation of schizophrenia Guillena, S.L. Romero
2015
25 S2 p. S541-S542
2 p.
artikel
547 P2.f.018 Effect of adjunctive brexpiprazole (OPC-34712) on depressive symptoms in patients with symptoms of anxious distress: results from post-hoc analyses Weiller, E.
2015
25 S2 p. S444-S445
2 p.
artikel
548 P.5.f.002 Effect of antidepressant and anxiolytics on development of diabetes mellitus inpatients with Alzheimer's disease Lim, K.Y.
2015
25 S2 p. S592-S593
2 p.
artikel
549 P.3.f.014 Effects of PANSS audio/video recordings on the presence of identical scorings across visits Kott, A.
2015
25 S2 p. S543-S544
2 p.
artikel
550 P.2.f.014 Effects of vortioxetine on resting-state activity in subjects remitted from depression and healthy controls Conen, S.
2015
25 S2 p. S442-
1 p.
artikel
551 P.6.f.007 Efficacy of behavioural drug and risk counseling for patients in methadone maintenance treatment in Jakarta, Indonesia: a randomised clinical trial Nurhidayat, A.W.
2015
25 S2 p. S631-S632
2 p.
artikel
552 P.5.f.005 Escitalopram in treatment of narcolepsy – case report Manusheva, N.
2015
25 S2 p. S593-S594
2 p.
artikel
553 P.1.f.015 Evidence for central molecular changes and changes to neuronal activity in an animal model of inflammatory bowel disease Dempsey, E.
2015
25 S2 p. S233-S234
2 p.
artikel
554 P.3.f.018 Evolution of anhedonia and depressive symptoms in Romanian outpatients diagnosed with major depressive episode and treated with agomelatine Tudose, C.
2015
25 S2 p. S545-S546
2 p.
artikel
555 P.2.f.027 Facial emotion recognition in patients with treatment resistant depressive disorder before and after repetitive TMS: preliminary results Dalkiran Varkal, M.
2015
25 S2 p. S450-
1 p.
artikel
556 P.3.f.001 Factors associated with re-hospitalizations in schizophrenia: a community mental health service research Varlik, D. Sarikaya
2015
25 S2 p. S536-S537
2 p.
artikel
557 P.3.f.007 Food intake, physical activity and constipation among inpatients with schizophrenia Renemane, L.
2015
25 S2 p. S539-
1 p.
artikel
558 P.2.f.017 Fronto-limbic connectivity in depression predicts response to SSRI administration Vai, B.
2015
25 S2 p. S444-
1 p.
artikel
559 P.4.f.004 Genetic and clinical contributions underlying symptom dimension stability in adult obsessive-compulsive disorder Mazza, M.G.
2015
25 S2 p. S576-
1 p.
artikel
560 P.7.f.005 Homeostatic brain correlates of acute social stress in excess weight adolescents Martín-Pérez, C.
2015
25 S2 p. S652-S653
2 p.
artikel
561 P.7.f.008 How do psychiatrists recommend children and adolescents to use the smartphones Kim, Y.
2015
25 S2 p. S653-
1 p.
artikel
562 P.6.f.003 Identification of food craving biomarkers and potential drug targets in obesity: clusterin and serum amyloid p-component Rodriguez-Rivera, C.
2015
25 S2 p. S628-S629
2 p.
artikel
563 P.1.f.023 Increased prolyl endopeptidase induces alterations in the expression of neural cell adhesion molecule in SH-SY5Y neuroblastoma cells Jaako, K.
2015
25 S2 p. S237-S238
2 p.
artikel
564 P.3.f.016 Initial medical work-up in first episode psychosis Coentre, R.
2015
25 S2 p. S544-S545
2 p.
artikel
565 P.3.f.003 In search of an affordable post-discharge intervention for patients with severe mental illness in a developing country Botha, U.
2015
25 S2 p. S537-S538
2 p.
artikel
566 P.1.f.014 Interleukin-2, Interleukin-23A and their SNP's in schizophrenia Ghazaryan, H.
2015
25 S2 p. S233-
1 p.
artikel
567 P.1.f.008 In vivo, in vitro and behavioural effects of intracerebral injection of neuro-Behcet's disease immunoglobulin and sera to brain parenchyma Erdag, E.
2015
25 S2 p. S229-
1 p.
artikel
568 P.1.f.010 Is tumor necrosis factor-alpha a sensitive marker of acute exacerbation of severe mental illnesses? Dunjić-Kostić, B.
2015
25 S2 p. S230-S231
2 p.
artikel
569 P.1.f.018 Lipopolysaccharide administration influences on brain activation in rats differing in responsiveness to novelty Wądołowska, A.
2015
25 S2 p. S234-
1 p.
artikel
570 P.2.f.019 Liver function test abnormalities in depressed patients treated with antidepressants: an observational cohort study in a psychiatric department Martin, S.
2015
25 S2 p. S445-S446
2 p.
artikel
571 P.2.f.016 Long-term outcomes in treatment of depression with venlafaxine ER 75–225 mg/d in the acute and continuation phases (PREVENT study) Kikuchi, T.
2015
25 S2 p. S443-S444
2 p.
artikel
572 P.3.f.025 Metabolic syndrome in patients with severe mental illness: prevalence and associated factors Mahia, M.C. Garcia
2015
25 S2 p. S550-
1 p.
artikel
573 P.1.f.019 Methodological aspects of translocator protein positron emission tomography for microglial activation in schizophrenia patients De Picker, L.
2015
25 S2 p. S234-S235
2 p.
artikel
574 P.1.f.009 Morningness and eveningness type in patients with multiple sclerosis and relation with clinical severity Gultekin, G.
2015
25 S2 p. S229-S230
2 p.
artikel
575 P.1.f.022 NLRP3-inflammasome complex is implicated in depressive behaviour induced by stress Alcocer-Gómez, E.
2015
25 S2 p. S236-S237
2 p.
artikel
576 P.2.f.015 Omega-3 polyunsaturated fatty acids for major depressive disorder: an updated meta-analysis of randomised clinical trials Mocking, R.J.T.
2015
25 S2 p. S442-S443
2 p.
artikel
577 P.3.f.020 Plasma lipid levels in suicide and non-suicide attempters diagnosed with delusional disorder González-Rodríguez, A.
2015
25 S2 p. S547-
1 p.
artikel
578 P.7.f.002 Prevalence of distorted body image in young Koreans and its association with age, sex, body weight status, and disordered eating behaviours Jung, Y.
2015
25 S2 p. S651-
1 p.
artikel
579 P.6.f.006 Prevalence of dual pathology in a community mental health setting Quintana, A. Fernández
2015
25 S2 p. S631-
1 p.
artikel
580 P.3.f.013 Prevalence of medical comorbidity in patients with schizophrenia Kim, S.
2015
25 S2 p. S542-S543
2 p.
artikel
581 P.3.f.009 Prevalence of metabolic syndrome in a sample of adults with severe mental illness treated with antipsychotic medication Ferreiro-Fernández, B.
2015
25 S2 p. S540-
1 p.
artikel
582 P.6.f.005 Prevalence of substance use and the relation with psychosis and catechol-O-methyltransferase in patients with chromosome 22q11 deletion syndrome Vingerhoets, W.A.M.
2015
25 S2 p. S630-
1 p.
artikel
583 P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study Costoloni, G.
2015
25 S2 p. S447-
1 p.
artikel
584 P.7.f.004 Psychopharmacological treatment of children with and without parental care: attitudes and decisions Dronjak, D.
2015
25 S2 p. S652-
1 p.
artikel
585 P.7.f.003 Public perspectives on pharmacological treatment of attention-deficit hyperactivity disorder Nam, B.
2015
25 S2 p. S651-S652
2 p.
artikel
586 P.7.f.001 Relationship between depressed mood, body mass index, and body weight perception in Korean adolescents Lim, Y.
2015
25 S2 p. S650-S651
2 p.
artikel
587 P.6.f.004 Relationship of lifetime substance use and posttraumatic stress disorder among Turkish university students Evren, C.
2015
25 S2 p. S629-S630
2 p.
artikel
588 P.2.f.021 Results of a double-blind placebo-controlled study of the antidepressant effects of the mGLU2 negative allosteric modulator RG1578 Umbricht, D.
2015
25 S2 p. S447-
1 p.
artikel
589 P.3.f.004 Roots to clinical prognosis in first episode psychosis of schizophrenia data from EUFEST study Matei, V.
2015
25 S2 p. S538-
1 p.
artikel
590 P.3.f.028 Schizophrenia and offense recidivism Oueslati, B.
2015
25 S2 p. S552-
1 p.
artikel
591 P.3.f.026 Season of birth in schizophrenia in a lower latitude country of northern hemisphere – Bangladesh perspective Mazumder, A.H
2015
25 S2 p. S550-S551
2 p.
artikel
592 P.1.f.011 Serum levels of interleukin-6 and interleukin-10 in acute phase with regard to clinical stabilisation in paranoid schizophrenic inpatients Díaz-Mesa, E.
2015
25 S2 p. S231-
1 p.
artikel
593 P.1.f.013 Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia Gene, A.
2015
25 S2 p. S232-S233
2 p.
artikel
594 P.6.f.009 Shopping dependence among women with eating disorders de Pablo, G. Salazar
2015
25 S2 p. S632-S633
2 p.
artikel
595 P.3.f.008 Specificity of mental disorders and social danger as prognostic factor of involuntary treatment of patients in mental hospital Renemane, L.
2015
25 S2 p. S539-S540
2 p.
artikel
596 P.3.f.012 Subclinical depressive symptoms and continued cannabis use in first episode psychosis González-Ortega, I.
2015
25 S2 p. S542-
1 p.
artikel
597 P.2.f.011 Sustained effects of repetitive transcranial magnetic stimulation in moderate to severe depression Cevik, M.
2015
25 S2 p. S440-
1 p.
artikel
598 P.2.f.025 Switching from inadequate adjunctive treatments: Open-label study of brexpiprazole effects on depressive symptoms, cognitive and physical functioning Baker, R.
2015
25 S2 p. S448-S449
2 p.
artikel
599 P.2.f.020 Telephone-administered psychotherapy in combination with antidepressant medication for the acute treatment of major depressive disorder Corruble, E.
2015
25 S2 p. S446-
1 p.
artikel
600 P.2.f.006 Temperament and character inventory and response to antidepressant treatment De Carlo, V.
2015
25 S2 p. S437-
1 p.
artikel
601 P.4.f.002 The cognitive profile of early-onset obsessive-compulsive disorder; does age matter? Gottwald, J.
2015
25 S2 p. S574-S575
2 p.
artikel
602 P.5.f.001 The effectiveness of combination therapy with quetapine and valproic acid in delirium with aggressive tendency: a prospective, controlled trial study Kim, H.W.
2015
25 S2 p. S591-S592
2 p.
artikel
603 P.1.f.004 The effect of acute ketamine administration on NLRP3 inflammasome activation in a sub-chronic stress model of rats Unal, G.
2015
25 S2 p. S226-S227
2 p.
artikel
604 P.2.f.002 The effect of ketamine anesthesia on the efficacy of electroconvulsive therapy and cognitive functions in treatment-resistant depression Bodnar, A.
2015
25 S2 p. S434-S435
2 p.
artikel
605 P.3.f.019 The effect of thought disorders on remission of symptoms in schizophrenia Yalınçetin, B.
2015
25 S2 p. S546-S547
2 p.
artikel
606 P.6.f.001 The prevalence of benzodiazepine use in Isparta province (Turkey) was lower Akpinar, A.
2015
25 S2 p. S628-
1 p.
artikel
607 P.1.f.021 The role of key components of adaptive immune response in development of autism Yenkoyan, K.
2015
25 S2 p. S236-
1 p.
artikel
608 P.3.f.024 Tract-based statistics in first episode psychosis: preliminary results depending on substance abuse comorbidity Rondinoni, C.
2015
25 S2 p. S549-S550
2 p.
artikel
609 P.2.f.010 Treatment adherence and response to psychopharmacological treatment in borderline personality disorder with and without major depressive disorder Batmaz, S.
2015
25 S2 p. S439-S440
2 p.
artikel
610 P.2.f.005 Vortioxetine effects on overall patient functioning in patients with major depressive disorder Florea, I.
2015
25 S2 p. S436-
1 p.
artikel
611 P.1.g.082 Activation of cannabinoid system in nucleus accumbens affects cost-benefit decision making Vanani, Z. Fatahi
2015
25 S2 p. S279-S280
2 p.
artikel
612 P.1.g.067 Altered hippocampal glutamate signalling in a rat ‘dual-hit’ neurodevelopmental model of schizophrenia King, M.
2015
25 S2 p. S273-
1 p.
artikel
613 P.1.g.070 Amygdala inactivation produces antinociception without changing threatening-induced pain inhibition in mice Sorregotti, T.
2015
25 S2 p. S274-S275
2 p.
artikel
614 P.1.g.002 Anticonvulsant screening of novel calixarene derivatives containing gamma-aminobutyric acid moieties Nesterkina, M.
2015
25 S2 p. S238-S239
2 p.
artikel
615 P.1.g.019 Antidepressant- and anxiolytic-like properties of S 47445, a novel positive allosteric modulator of AMPA type glutamate receptors Bretin, S.
2015
25 S2 p. S248-S249
2 p.
artikel
616 P.1.g.012 Antinociceptive effect of two adaptogenic medicinal plants in rats Vasileva, L.
2015
25 S2 p. S244-
1 p.
artikel
617 P.1.g.011 Antinociceptive effects of ketamine and alpha-lipoic acid in rats with neuropathic pain Doncheva, N.
2015
25 S2 p. S243-S244
2 p.
artikel
618 P.1.g.021 Antinociceptive effects of maprotiline in a rat model of peripheral neuropathic pain: Possible involvement of opioid system Banafshe, H.R.
2015
25 S2 p. S249-
1 p.
artikel
619 P.1.g.075 Antipsychotic effects on corticosterone plasma level and glucocorticoid receptor expression in the rat brain perinatally treated with phencyclidine Nikolic, T.
2015
25 S2 p. S277-
1 p.
artikel
620 P.1.g.006 Antipsychotic treatment and metabolic syndrome: a comparison between schizophrenic and bipolar patients Prisco, V.
2015
25 S2 p. S241-
1 p.
artikel
621 P.1.g.036 Aripiprazole-induced activation of adenylate cyclase and relaxation effects on smooth muscles Prissadova, N.
2015
25 S2 p. S256-
1 p.
artikel
622 P.1.g.017 Assessment of cognitive impairments in a rat depression model using the touchscreen operant platform Wiborg, O.
2015
25 S2 p. S247-
1 p.
artikel
623 P1.g.023 Atomoxetine for hoarding disorder: a preclinical and clinical investigation Grassi, G.
2015
25 S2 p. S249-S250
2 p.
artikel
624 P.1.g.028 Attention deficit and hyperactivity disorder – the pharmacological approach in our clinic Irimie-Ana, A.
2015
25 S2 p. S252-S253
2 p.
artikel
625 P.1.g.047 Biological profiling of antidepressant response in depression: associations with neuroinflammation, fatty acid metabolism, and amygdala-reactivity Mocking, R.J.T.
2015
25 S2 p. S262-S263
2 p.
artikel
626 P.1.g.048 Blockade of CB1 cannabinoid receptors and activation of CB2 interact to prevent cocaine-responses Gobira, P.
2015
25 S2 p. S263-S264
2 p.
artikel
627 P1.g.074 Brexpiprazole alters monoaminergic systems following its subacute and long-term administration: an in vivo electrophysiological study Oosterhof, C.A.
2015
25 S2 p. S276-S277
2 p.
artikel
628 P.1.g.004 Bupropion, but not fluvoxamine improves spatial memory acquisition in old rats Mititelu-Tartau, L.
2015
25 S2 p. S240-
1 p.
artikel
629 P.1.g.035 Caenorhabditis elegans as a model of obesity caused by antipsychotics Hellwig, I.
2015
25 S2 p. S255-S256
2 p.
artikel
630 P.1.g.049 Chronic etanercept treatment exerts antidepressant-like effect in cafeteria diet-fed rats Utkan, T.
2015
25 S2 p. S264-
1 p.
artikel
631 P.2.g.001 Chronic vortioxetine enhances synaptic plasticity via increased activity-regulated cytoskeletal (Arc) protein expression in young and middle-age mice Kugathasan, P.
2015
25 S2 p. S451-
1 p.
artikel
632 P.1.g.037 Clinical factors related with treatment adherence in psychotic patients with psychiatric hospitalisation experience Jung, M.H.
2015
25 S2 p. S256-S257
2 p.
artikel
633 P.1.g.062 Combined administration of oral tranylcypromine and intravenous S-ketamine in treatment-resistant depression: A case report Bartova, L.
2015
25 S2 p. S270-S271
2 p.
artikel
634 P.1.g.039 Comparison between systemic and central administration of methylene blue and nitroglycerin on orofacial nociceptive behavior in mice Bohotin, C.
2015
25 S2 p. S257-S258
2 p.
artikel
635 P.1.g.084 Could luminosity be part of the placebo effect in antidepressant trials? Gailledreau, J.
2015
25 S2 p. S280-S281
2 p.
artikel
636 P.1.g.076 Coumestrol protects against excitotoxicity and ischemia-induced reduction of GluR2 content and memory impairment Pagnussat, A.
2015
25 S2 p. S278-
1 p.
artikel
637 P.1.g.040 α2C-selective antagonism with ORM10921 decreases behavioural despair and improves cognition in the Flinders sensitive line rat model of depression Erasmus, M.
2015
25 S2 p. S258-S259
2 p.
artikel
638 P1.g.033 C-terminal fragment of arginine-vasopressin contributes more to the rate of memory trace formation, while its analog improves maintenance of the trace Belyakova, A.
2015
25 S2 p. S254-S255
2 p.
artikel
639 P.1.g.053 Diazepam's cytotoxic effect against U251 human glioma cell line, in vitro Isakovic, Andelka
2015
25 S2 p. S265-
1 p.
artikel
640 P.1.g.044 Dimeric dipeptide mimetics of the BDNF loop 4 and loop 1 activate TrkB with different patterns of intracellular signal transduction Logvinov, I.
2015
25 S2 p. S260-S261
2 p.
artikel
641 P.1.g.042 Direct inhibition of retinoic acid catabolism by fluoxetine Hellmann-Regen, J.
2015
25 S2 p. S260-
1 p.
artikel
642 P.1.g.009 Dissociable effects of mGluR5 modulation on motor and choice impulsivity in rats: interaction with NMDA receptor antagonism Pekcec, A.
2015
25 S2 p. S242-S243
2 p.
artikel
643 P.1.g.007 Effect of chronic etanercept (a TNF-α inhibitor) treatment on depressive-like behaviour in aged rats Demirtas, T.
2015
25 S2 p. S241-S242
2 p.
artikel
644 P.1.g.024 Effects of antipsychotic treatment on obsessive-compulsive symptoms in schizophrenia Zink, M.
2015
25 S2 p. S250-S251
2 p.
artikel
645 P.1.g.038 Effects of different doses of the new antiepileptic drug lacosamide on learning and memory abilities in rats Shishmanova, M.
2015
25 S2 p. S257-
1 p.
artikel
646 P.1.g.026 Efficient strategy for obtaining reliable pharmacokinetic parameters in population compartmental approaches Lee, J.
2015
25 S2 p. S251-S252
2 p.
artikel
647 P.1.g.065 Excitatory glutamate component involved in the electrophysiological response of ventral tegmental area dopamine neurons to methylphenidate Di Miceli, M.
2015
25 S2 p. S271-S272
2 p.
artikel
648 P.1.g.045 Functional interaction between serotonin 2A and metabotropic glutamate 2 receptors in the regulation of dopamine release in mouse prefrontal cortex Mollinedo-Gajate, I.
2015
25 S2 p. S261-S262
2 p.
artikel
649 P.1.g.059 Further evidences of the efficacy of agomelatine in animal models of neuropathic pain Mocaer, E.
2015
25 S2 p. S268-S269
2 p.
artikel
650 P.1.g.031 GABAergic dysfunction in late-life anxiety: the role of BDNF Zhou, N.
2015
25 S2 p. S253-
1 p.
artikel
651 P.1.g.072 Genetic polymorphisms of OPRM1 gene and their impact on methadone maintenance treatment in opioid addicts: A systematic review of the literature Oueslati, B.
2015
25 S2 p. S275-
1 p.
artikel
652 P.1.g.060 Genome-wide analysis of lipopolysaccharide (LPS)-induced inflammatory response in the rat ventral hippocampus: modulatory activity of the antidepressant agomelatine Rossetti, A.C.
2015
25 S2 p. S269-
1 p.
artikel
653 P.1.g.013 Identification of novel bioactives on the alpha-7-nAChR using an at-line cellular bioassay after nanofractionation Otvos, R.A.
2015
25 S2 p. S244-S245
2 p.
artikel
654 P.1.g.014 Intracellular signaling pathways implicated in the antidepressant-like effect of ursolic acid in the tail suspension test Hryb, A.B. Ramos
2015
25 S2 p. S245-S246
2 p.
artikel
655 P.1.g.055 Intranasal oxytocin dampens amygdala reactivity and normalises amygdala connectivity in PTSD patients Koch, S.B.J.
2015
25 S2 p. S266-S267
2 p.
artikel
656 P.1.g.008 Levodopa chronic treatment promotes reinforcing properties of pramipexole in alpha-synuclein rat model of Parkinson's disease Loiodice, S.
2015
25 S2 p. S242-
1 p.
artikel
657 P.1.g.005 Long term ghrelin agonist treatment in mice does not increase weight but reduces fat mass in specific anatomical regions Kunath, N.
2015
25 S2 p. S240-S241
2 p.
artikel
658 P.1.g.046 Neuronal circuits involved in vortioxetine-improved pattern separation in mice: role of the serotonin1B (5-HT1B) receptor Felice, D.
2015
25 S2 p. S262-
1 p.
artikel
659 P.1.g.015 Off-rate may characterise the pharmacological profile of phosphodiesterase 10A inhibitors via modulation of activation of direct and indirect pathways Suzuki, K.
2015
25 S2 p. S246-
1 p.
artikel
660 P.1.g.001 Opposite effects of different classes of antidepressants in the open space swimming test in the mouse Castagné, V.
2015
25 S2 p. S238-
1 p.
artikel
661 P1.g.061 Orexin receptor type 1 (Ox1R) are involved in the formation and reinstatement of conditioned place preference Tissen, I.
2015
25 S2 p. S269-S270
2 p.
artikel
662 P.1.g.073 Pharmacological MRI: a tool to understand the paradoxical effects of serotonergic type 6 receptors modulation? Asselot, R.
2015
25 S2 p. S276-
1 p.
artikel
663 P1.g.068 Phosphorylation of TRPV1 located within the dorsal periaqueductal gray enhances social defeat stress-induced analgesia in mice Mascarenhas, D.
2015
25 S2 p. S273-S274
2 p.
artikel
664 P.1.g.056 Potent and sustained anti-hyperalgesic and anti-allodynic effects of chronic administration of agomelatine in neuropathic rats Dabala, E.
2015
25 S2 p. S267-
1 p.
artikel
665 P.1.g.032 Protective effects of the phenolic compounds of Gastrodia elata Blume on cerebral ischemic injury by reconstruction of neurovascular unit homeostasis Rong, D.
2015
25 S2 p. S254-
1 p.
artikel
666 P.1.g.066 Proteolytic hydrolysis of myelin basic protein by IgGs during long-term treatment of schizophrenia Parshukova, D.
2015
25 S2 p. S272-S273
2 p.
artikel
667 P1.g.057 Psychiatric adverse effects of adjunctive levetiracetam for epilepsy in children and adolescents Ninkovic, M.
2015
25 S2 p. S267-S268
2 p.
artikel
668 P.1.g.069 Relationship between dose, plasma concentration and GABA-A receptor occupancy by partial GABA-A receptor modulators Jucaite, A.
2015
25 S2 p. S274-
1 p.
artikel
669 P.1.g.041 RG1662, a new negative allosteric modulator of the gamma-aminobutyric acid Aα5 receptor subtype, does not show convulsions at relevant doses Wandel, C.
2015
25 S2 p. S259-
1 p.
artikel
670 P.1.g.052 Serotonin transporter-independent actions of the antidepressant vortioxetine as revealed in studies of the SERT Met172 mouse Nackenoff, A.
2015
25 S2 p. S264-S265
2 p.
artikel
671 P.1.g.064 Stimulation of the dorsal raphe nucleus lateral wings activates neural structures involved in the modulation of panic-like defensive behaviours Matthiesen, M.
2015
25 S2 p. S271-
1 p.
artikel
672 P.1.g.083 Studies on some mechanisms of central nervous activity of two newly synthesized neuropeptides Stoeva, S.
2015
25 S2 p. S280-
1 p.
artikel
673 P.1.g.018 Study of the effects of serotonin 1B/1D selective agonists – eletriptan and rizatriptan on pain reactions Saracheva, K.
2015
25 S2 p. S247-S248
2 p.
artikel
674 P.2.g.003 Suicidal ideation in primary care patients: comorbidity with depression, anxiety disorders, and somatic diagnoses Liaugaudaite, V.
2015
25 S2 p. S452-S453
2 p.
artikel
675 P.1.g.027 TAK-063, a novel phosphodiesterase 10A inhibitor, produces antipsychotic-like effects through balanced activation of indirect and direct pathways Kimura, H.
2015
25 S2 p. S252-
1 p.
artikel
676 P.1.g.025 The clinical and pharmacogenetic factors affecting the disposition of oxycodone Cho, D.
2015
25 S2 p. S251-
1 p.
artikel
677 P.1.g.077 The discovery of RG1578: a metabotropic glutamate receptor 2/3 negative allosteric modulator with antidepressant and cognitive enhancing properties Gatti, S.
2015
25 S2 p. S278-S279
2 p.
artikel
678 P.1.g.079 The effects of lithium and valproate on BDNF levels in the hippocampus of mice on the model mania-like induced by GBR 12909 Rodrigues, F.T.S.
2015
25 S2 p. S279-
1 p.
artikel
679 P.1.g.003 The effects of zinc entrapped in nanovesicles on memory processes performance in rats Mititelu-Tartau, L.
2015
25 S2 p. S239-
1 p.
artikel
680 P.1.g.034 Treatment with multiple antipsychotics in psychiatric inpatients Ferreiro-Fernández, B.
2015
25 S2 p. S255-
1 p.
artikel
681 P.1.g.010 Use of chronically administered adipokinetic hormone in depression, anxiety and pain Mutlu, O.
2015
25 S2 p. S243-
1 p.
artikel
682 P.2.g.002 Vortioxetine blocks serotonin excitation of GABAergic interneurons and disinhibits pyramidal cell activity in the rat hippocampus Dale, E.
2015
25 S2 p. S451-S452
2 p.
artikel
683 P.2.g.004 Vortioxetine promotes maturation of dendritic spines – an in vitro study in hippocampal cultures Waller, J.A.
2015
25 S2 p. S453-
1 p.
artikel
684 P.1.g.016 Why direct intracerebroventricular injection of 3,4-methylenedioxymethamphetamine (ecstasy) failed to produce serotonin syndrome in animal models? Shokry, I.M.
2015
25 S2 p. S246-S247
2 p.
artikel
685 P.1.g.054 Zinc reduces morphine dependence with no effect on pain perception in rats – possible beneficial role of zinc supplementation in opioid-users Ciubotariu, D.
2015
25 S2 p. S265-S266
2 p.
artikel
686 P.2.h.013 An ethnographic study of the impact of cognitive dysfunction on patients with major depressive disorder Ebert, B.
2015
25 S2 p. S461-
1 p.
artikel
687 P1.h.010 Behavioural characterisation of dehydroepiandrosterone effects in rats: further evaluation and the role of GABA(A) receptors Samardzic, J.
2015
25 S2 p. S286-S287
2 p.
artikel
688 P.1.h.024 Chronic magnesium administration ameliorates depressive- and anxiety-like behaviour in ACTH-treated rats Petrovic, J.
2015
25 S2 p. S294-S295
2 p.
artikel
689 P.1.h.002 Correction of fighting deprivation effect in male mice with repeated experience of aggression Smagin, D.
2015
25 S2 p. S282-
1 p.
artikel
690 P.1.h.017 Differential regulation of Zinc Transporters type 1, 3 and 4 in the brain of rats subjected to olfactory bulbectomy model of depression Rafalo, A.
2015
25 S2 p. S290-
1 p.
artikel
691 P.1.h.020 Dose dependent effects of obestatin fragment (1–4) on body weight gain, food and water consumption, and attendant changes in stress level Motorykina, E.
2015
25 S2 p. S292-
1 p.
artikel
692 P.1.h.007 Early communication by ultrasound vocalisation in vasopressin deficient Brattleboro rats, implication on schizophrenia Fodor, A.
2015
25 S2 p. S285-
1 p.
artikel
693 P.2.h.008 Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder: subgroup analyses Vieta, E.
2015
25 S2 p. S458-
1 p.
artikel
694 P.1.h.003 Effect of congenital and acquired hypothyroidism on forced swimming test in juvenile rats Ozgur, B. Gurbuz
2015
25 S2 p. S282-S283
2 p.
artikel
695 P.1.h.021 Effect of fluoxetine and MIML4–11, a novel tropomyosin-related kinase receptor agonist, in a lipopolysaccharide-induced model of depression Levy, M.J.F.
2015
25 S2 p. S292-S293
2 p.
artikel
696 P.2.h.012 Effect of vortioxetine on functional capacity in patients with major depressive disorder with self-reported cognitive dysfunction Jacobson, W.
2015
25 S2 p. S460-
1 p.
artikel
697 P.2.h.007 Effects of antidepressants on temperament, character and defense mechanisms in major depression Tabakci, A.S
2015
25 S2 p. S457-
1 p.
artikel
698 P.1.h.006 Effects of antipsychotic drugs asenapine, paliperidone, quetiapine and aripiprazole on pain and locomotion in mice Oguz, M.
2015
25 S2 p. S284-S285
2 p.
artikel
699 P.1.h.011 Effects of positive α5-selective modulation of GABAA receptors on amphetamine-induced hyperactivation Stamenic, T. Timic
2015
25 S2 p. S287-S288
2 p.
artikel
700 P.1.h.030 Enduring erasure of remote fear memories by the blockade of calcium-permeable AMPA receptors applied before extinction training Balazsfi, D.
2015
25 S2 p. S297-S298
2 p.
artikel
701 P.1.h.018 Enhancement of locomotor activity following intraseptal NMDA glutamate receptor agonist injection in high and low responders to novelty Podlacha, M.
2015
25 S2 p. S290-S291
2 p.
artikel
702 P.1.h.012 Functional reorganisation of the mesolimbic dopaminergic system after amphetamine injection into its terminal area Plucinska, K.
2015
25 S2 p. S288-
1 p.
artikel
703 P.1.h.031 Functional reorganization of the mesolimbic dopaminergic system after its terminal area glutamate injection Plucinska, K.
2015
25 S2 p. S298-S299
2 p.
artikel
704 P.2.h.005 Gut microbiome alterations in major depressive disorder: relevance to pathophysiology Kelly, J.R.
2015
25 S2 p. S456-
1 p.
artikel
705 P.1.h.016 Impact of stress on neuronal plasticity in rats Geoffroy, H.
2015
25 S2 p. S289-S290
2 p.
artikel
706 P.2.h.016 Interleukin-6 antibody Sirukumab improves depressive symptoms in a randomized, placebo-controlled, phase 2 study in patients with rheumatoid arthritis Wang, D.
2015
25 S2 p. S462-
1 p.
artikel
707 P.2.h.009 Maintenance of vortioxetine efficacy with long-term treatment of patients with major depressive disorder Vieta, E.
2015
25 S2 p. S458-S459
2 p.
artikel
708 P.2.h.002 Medication discrepancies in outpatients with mood and anxiety disorders. Risks and clinical relevance Simoons, M.
2015
25 S2 p. S454-
1 p.
artikel
709 P.2.h.011 Meta-analysis of cognitive function in vortioxetine clinical trials in major depressive disorder McIntyre, R.
2015
25 S2 p. S459-S460
2 p.
artikel
710 P.1.h.022 Mice haploinsufficient for Map2k7, a schizophrenia risk gene, show impaired associative learning and attentional deficits: Impact of minocycline Openshaw, R.
2015
25 S2 p. S293-
1 p.
artikel
711 P.2.h.006 PAPA: Pharmacokinetics in Pregnancy and Antidepressant drugs Reis, M.
2015
25 S2 p. S456-S457
2 p.
artikel
712 P.2.h.001 Plasma apolipoprotein E and severity of suicidal behaviour Asellus, P.
2015
25 S2 p. S453-S454
2 p.
artikel
713 P.1.h.025 Potential involvement of metabotropic glutamate 2/3 receptors on trazodone effect on hyperalgesia in the chronic constriction injury rat model Garrone, B.
2015
25 S2 p. S295-
1 p.
artikel
714 P.1.h.009 Protective effects of an extract of propolis in scopolamine-induced cognitive impairment in rats Gocmez, S.
2015
25 S2 p. S286-
1 p.
artikel
715 P.2.h.003 Reduction in depressed mood after dietary supplementation during postpartum blues Dowlati, Y.
2015
25 S2 p. S455-
1 p.
artikel
716 P.1.h.029 Role of the endocannabinoid system in the behavioral alterations observed in the rat valproic acid model of autism Servadio, M.
2015
25 S2 p. S297-
1 p.
artikel
717 P.1.h.008 Social behaviour in deer mice as a novel interactive paradigm of relevance for obsessive-compulsive disorder (OCD) Wolmarans, P.
2015
25 S2 p. S285-S286
2 p.
artikel
718 P.1.h.023 Stimulation of the central nucleus of the amygdala increases anxiety-related behaviour Rucinski, J.
2015
25 S2 p. S294-
1 p.
artikel
719 P.1.h.028 Structural and neurochemical changes in the anterior cingulate cortex (ACC) are associated with aggression and global attention deficits: A study in the BALB/cJ mouse Jager, A.
2015
25 S2 p. S296-S297
2 p.
artikel
720 P.1.h.027 Study of anxiolytic effects of kami kihi to (gui pi tang) in rats Polly, M.
2015
25 S2 p. S296-
1 p.
artikel
721 P.2.h.004 The changes of psychometric profiles after treatment of lower urinary tract symptoms suggestive of benign prostate hyperplasia Jeong, W.J.
2015
25 S2 p. S455-S456
2 p.
artikel
722 P.1.h.005 The deficit in anticipatory motivation as a negative symptom of schizophrenia: phencyclidine treated rats exhibit pessimism in an optimistic bias task Sahin, C.
2015
25 S2 p. S283-S284
2 p.
artikel
723 P.2.h.010 The effect of poststroke depression on functional outcome Slankamenac, P.
2015
25 S2 p. S459-
1 p.
artikel
724 P.1.h.026 The effects of repeated disulfiram and nitroglycerin on thermonociception and visceral pain in mice Luca, A.
2015
25 S2 p. S295-S296
2 p.
artikel
725 P.1.h.019 The effects of swimming exercises, calorie restraction or l-carnitine treatment on behavior parameters, cognitive functions in high fat diet fed rats Golgeli, A.
2015
25 S2 p. S291-S292
2 p.
artikel
726 P.1.h.001 The effects of various doses of imidazoline receptor antagonist idazoxan on psychomotor abilities and spatial memory in rats Rusu, G.
2015
25 S2 p. S281-
1 p.
artikel
727 P.1.h.004 The involvement of the medial prefrontal cortex and basolateral amygdala in the regulation of coping with stressors Mano, A.
2015
25 S2 p. S283-
1 p.
artikel
728 P.1.h.014 Time dependent sensitisation exaggerates depressive-like symptoms in Flinders sensitive line (FSL) rats, a genetic animal model of depression Brand, S.
2015
25 S2 p. S288-S289
2 p.
artikel
729 P.2.h.014 Treatment with fluoxetine in adolescents may aggravate emotional dysregulation: a power analysis for future studies Bottelier, M.A
2015
25 S2 p. S461-S462
2 p.
artikel
730 P.1.i.038 Activity in the parahippocampal gyrus during cognitive tasks correlates with the tendency to ruminate Piguet, C.
2015
25 S2 p. S322-S323
2 p.
artikel
731 P.1.i.039 Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on hippocampal glutamate and GABA levels Solowij, N.
2015
25 S2 p. S323-
1 p.
artikel
732 P.1.i.043 Age-dependent effects of selective serotonin reuptake inhibitor exposure on the development of the GABA-ergic system Solleveld, M.M
2015
25 S2 p. S325-S326
2 p.
artikel
733 P.1.i.019 A randomised double blind controlled trial of neuronavigated repetitive transcranial magnetic stimulation in anorexia nervosa McClelland, J.
2015
25 S2 p. S310-
1 p.
artikel
734 P.1.i.041 A retrospective open-label study to compare antidepressant efficacy of repetitive transcranial magnetic stimulation using two different devices Oliveira-Maia, A.J.
2015
25 S2 p. S324-S325
2 p.
artikel
735 P.1.i.036 Binding potential of 5-HTT in patients with obsessive compulsive disorder during SSRI treatment Euitae, K.
2015
25 S2 p. S321-
1 p.
artikel
736 P.1.i.050 Brain activation during set-shifting in relation to subclinical apathy Klaasen, N.G.
2015
25 S2 p. S329-
1 p.
artikel
737 P.1.i.033 Brain correlates of the desire to food predict body mass index change in excess weight adults Contreras-Rodríguez, O.
2015
25 S2 p. S319-
1 p.
artikel
738 P.1.i.025 Brain PET measurement of phosphodiesterase 10A occupancy by TAK-063, a new phosphodiesterase 10A inhibitor, using [11C]T-773 in nonhuman primates Takano, A.
2015
25 S2 p. S313-S314
2 p.
artikel
739 P.1.i.028 Brain phosphodiesterase 10A occupancy measured by PET after oral administration of TAK-063, a newly developed phosphodiesterase 10A inhibitor, in human volunteers Takano, A.
2015
25 S2 p. S316-
1 p.
artikel
740 P.1.i.009 Cerebral monoamine oxidase A distribution volume in seasonal affective disorder Baldinger, P.
2015
25 S2 p. S304-
1 p.
artikel
741 P.1.i.020 Changes in apparent diffusion coefficient values in patients with multiple sclerosis with regard to treatment with interferon beta Gondek, T.M
2015
25 S2 p. S310-S311
2 p.
artikel
742 P.1.i.008 Comparison of white matter connectivity between treatment responder and non-responder in patients with panic disorder Choi, T.K
2015
25 S2 p. S303-
1 p.
artikel
743 P.1.i.014 Cortical connectivity in adolescents and young adults with attention-deficit/hyperactivity disorder Forde, N.
2015
25 S2 p. S307-
1 p.
artikel
744 P.1.i.042 Cortical thickness changes in individuals at risk of psychosis Sasabayashi, D.
2015
25 S2 p. S325-
1 p.
artikel
745 P.1.i.052 Decreased cortical folding in patients with bipolar disorder and psychotic features: an international multicenter study Sarrazin, S.
2015
25 S2 p. S330-
1 p.
artikel
746 P.1.i.031 Deficits in context dependent adaptive coding of reward values in schizophrenia Kirschner, M.
2015
25 S2 p. S318-
1 p.
artikel
747 P.1.i.035 Differentiation between first-episode psychosis patients and healthy subjects on the basis of precuneus activation Rikandi, E.
2015
25 S2 p. S320-S321
2 p.
artikel
748 P.1.i.022 Effect of brain-derived neurotrophic factor genotype, gene expression and serum protein levels and childhood maltreatment on regional brain volume Van Velzen, L.S.
2015
25 S2 p. S312-
1 p.
artikel
749 P1.i.029 Effect of catechol-O-methyltransferase polymorphism on subcortical volumes in schizophrenia Spangaro, M.
2015
25 S2 p. S316-S317
2 p.
artikel
750 P.1.i.011 Effect of delta-9-tetrahydrocannabinol on the whole-brain resting state functional connectivity: a dynamic connectivity approach Zaytseva, Y.
2015
25 S2 p. S305-
1 p.
artikel
751 P.1.i.040 Effects of intranasal oxytocin on reward anticipation in patients with post-traumatic stress disorder: an fMRI study Nawijn, L.
2015
25 S2 p. S323-S324
2 p.
artikel
752 P.1.i.037 Effects of norepinephrine transporter gene variants on protein binding in patients with ADHD using PET Sigurdardottir, H.
2015
25 S2 p. S321-S322
2 p.
artikel
753 P.1.i.016 Fronto-insular network and prefrontal GABA levels following targeted transcranial theta-burst magnetic stimulation Iwabuchi, S.J
2015
25 S2 p. S308-S309
2 p.
artikel
754 P.1.i.006 Further human evidence for striatal dopamine release induced by administration of Δ9-tetrahydrocannabinol (THC) Bossong, M.G
2015
25 S2 p. S302-
1 p.
artikel
755 P.1.i.034 Gene expression and protein distribution of serotonergic key proteins in the human brain revealed by PET in vivo and postmortem quantification Komorowski, A.
2015
25 S2 p. S319-S320
2 p.
artikel
756 P.1.i.055 Generalized anxiety disorder is characterised by a non-discriminative response of the ventromedial prefrontal cortex during fear learning Via Virgili, E.
2015
25 S2 p. S331-S332
2 p.
artikel
757 P.1.i.007 Glutamatergic activity measured by 1H-MRS is decreased in euthymic bipolar I disorder subjects Soeiro-de-Souza, M.
2015
25 S2 p. S302-S303
2 p.
artikel
758 P.1.i.017 How antimanic treatment via tamoxifen may affect the brain's chemistry – a double-blind placebo-controlled 1H MRS study Yildiz, A.
2015
25 S2 p. S309-
1 p.
artikel
759 P.1.i.021 Improvement of well-being measures after regular physical exercise correlates with resting state connectivity in attentional and default mode networks Tozzi, L.
2015
25 S2 p. S311-S312
2 p.
artikel
760 P.1.i.015 Impulsive aggression in misophonia: results from a functional magnetic resonance imaging study Schröder, A.
2015
25 S2 p. S307-S308
2 p.
artikel
761 P.1.i.046 Influence of adverse childhood experience on gray matter volume in major psychosis compared to healthy controls Melloni, E.M.T.
2015
25 S2 p. S327-
1 p.
artikel
762 P.1.i.051 Intermittent Theta Burst Stimulation of the left dorsolateral prefrontal cortex for the treatment of persistent negative symptoms in schizophrenia Bation, R.
2015
25 S2 p. S329-S330
2 p.
artikel
763 P.1.i.032 Interpolation of sparse mRNA samples to create comprehensive atlases of cerebral protein transcription Gryglewski, G.
2015
25 S2 p. S318-S319
2 p.
artikel
764 P.1.i.047 Interregional changes in serotonin transporter availability upon treatment with selective serotonin reuptake inhibitors James, G.
2015
25 S2 p. S327-S328
2 p.
artikel
765 P.1.i.004 Lead-induced impairments in neural processes in relation to executive function Kim, Y.T.
2015
25 S2 p. S300-S301
2 p.
artikel
766 P.1.i.053 Low behavioural pattern separation is linked to reduced dentate gyrus activation during fear generalisation Lange, I.
2015
25 S2 p. S330-S331
2 p.
artikel
767 P.1.i.056 Mass spectrometry imaging as a powerful tool for detailed molecular investigation of brain pathologies: molecular microscope for peroxisomal disorders Skraskova, K.
2015
25 S2 p. S332-
1 p.
artikel
768 P.1.i.013 Neural correlates of reactive aggression in psychopathic violent offenders; a functional magnetic resonance study Da Cunha-Bang, S.
2015
25 S2 p. S306-S307
2 p.
artikel
769 P.1.i.001 Neurocognitive effects of repetitive transcranial magnetic stimulation in drug free treatment-resistant depression patients Sayar, G. Hizli
2015
25 S2 p. S299-S300
2 p.
artikel
770 P.1.i.027 Quantitative analysis and test-retest reproducibility of a new phosphodiesterase 10A PET radioligand [11C]T-773 in human brain Takano, A.
2015
25 S2 p. S315-
1 p.
artikel
771 P.1.i.048 Seasonal variation in serotonin transporter binding in seasonal affective disorder and health: a [11C]DASB positron emission tomography study Tyrer, A.E
2015
25 S2 p. S328-
1 p.
artikel
772 P.1.i.023 Self-regulation of the dopaminergic reward system via real time fMRI neurofeedback: a novel treatment approach for cocaine addiction Kirschner, M.
2015
25 S2 p. S312-S313
2 p.
artikel
773 P.1.i.018 Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36: test-retest reproducibility and comparison with [18F]altanserin Ettrup, A.
2015
25 S2 p. S309-S310
2 p.
artikel
774 P.1.i.012 Serotonin transporter genotype moderates the effect of psychosocial stress on executive control and default mode network connectivity Van der Meer, D.
2015
25 S2 p. S305-S306
2 p.
artikel
775 P.1.i.010 Spectroscopy differences between at risk populations for psychosis Bloemen, O.
2015
25 S2 p. S304-S305
2 p.
artikel
776 P.1.i.024 The dopaminergic response to acute stress in health and psychopathology: a systematic review Vaessen, T.
2015
25 S2 p. S313-
1 p.
artikel
777 P.1.i.002 The effect of bilateral high frequency repetitive transcranial magnetic stimulation on cognition in schizophrenia: a pilot study Güleken, M.D.
2015
25 S2 p. S300-
1 p.
artikel
778 P.1.i.044 The effects of methylphenidate on striatal dopamine system are dependent on age: a pharmacological magnetic resonance imaging study Schrantee, A.
2015
25 S2 p. S326-S327
2 p.
artikel
779 P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers Preller, K.H.
2015
25 S2 p. S301-
1 p.
artikel
780 P.1.i.030 The modulatory role of catechol-O-methyltransferase Val158Met polymorphism on the association between white matter microstructure and cognitive performances in schizophrenia Aggio, V.
2015
25 S2 p. S317-S318
2 p.
artikel
781 P.1.i.026 Vortioxetine reduces BOLD signal during performance of the N-back task in subjects remitted from depression and healthy control participants Browning, M.
2015
25 S2 p. S314-S315
2 p.
artikel
782 P.1.j.018 A comparative study of cognitive impairment in patients at different stages of schizophrenia Dorofeikova, M.
2015
25 S2 p. S343-
1 p.
artikel
783 P.1.j.023 Alleviation of stress-induced cognitive decline by telmisartan goes beyond peroxisome proliferator-activated receptor gamma agonism, targeting HPA axis deactivation Wincewicz, D.
2015
25 S2 p. S345-S346
2 p.
artikel
784 P.1.j.007 An investigation of cognitive load during experimentally induced anxiety using pupillometry Hou, R.
2015
25 S2 p. S336-
1 p.
artikel
785 P.1.j.024 Application of a novel clustering approach in the investigation of cognitive functioning and overweightness Hoyer, J.
2015
25 S2 p. S346-
1 p.
artikel
786 P.1.j.030 Are schizophrenia patients worse performers of dual-tasking? Insights from motor timing Malania, M.
2015
25 S2 p. S349-S350
2 p.
artikel
787 P.1.j.009 Awareness of driving impairment: lapses versus excursions out-of-lane during highway driving Enkelaar, R.
2015
25 S2 p. S337-S338
2 p.
artikel
788 P.1.j.001 Cognitive deficit and social functioning in patients with first psychotic episode Berdzenishvili, E.
2015
25 S2 p. S332-S333
2 p.
artikel
789 P.1.j.022 Cognitive remediation in psychiatric patients with an online cognitive game and assessment tool Nieman, D.H
2015
25 S2 p. S344-S345
2 p.
artikel
790 P.1.j.036 Comparison of spatial processing in schizophrenia and bipolar disorder Tereszko, A.
2015
25 S2 p. S353-
1 p.
artikel
791 P.1.j.028 Differences in affective go/no go performance during acute stress and anxiety induced by CO2-enriched air are moderated by reaction time Van Ghesel Grothe, A.S.
2015
25 S2 p. S348-S349
2 p.
artikel
792 P.1.j.025 Effects of acute stress and anxiety induced by the inhalation of air enriched with CO2 on model-based and model-free behaviour Bruehl, A.
2015
25 S2 p. S346-S347
2 p.
artikel
793 P.1.j.017 Effects of chronic etanercept, a TNF-α inhibitor, on cognitive dysfunction in cafeteria diet-fed rats Demirtas, T.
2015
25 S2 p. S342-S343
2 p.
artikel
794 P.1.j.004 Effects of etifoxine on passive avoidance tests and locomotor activity in rats Kokova, V.
2015
25 S2 p. S334-S335
2 p.
artikel
795 P.1.j.014 Effects of gallic acid and quercetin on learning and memory processes in young/healthy rats Valcheva-Kuzmanova, S.
2015
25 S2 p. S340-S341
2 p.
artikel
796 P.1.j.034 Error processing and psychopathy in multiproblem young adults: preliminary EEG results Zijlmans, J.
2015
25 S2 p. S351-S352
2 p.
artikel
797 P.1.j.005 Facial emotion recognition among siblings discordant for schizophrenia Andric, S.
2015
25 S2 p. S335-
1 p.
artikel
798 P.1.j.020 Functioning of the posterior cingulate cortex predicts development of insight into one's illness in patients with first-episode psychosis Raij, T.T.
2015
25 S2 p. S343-S344
2 p.
artikel
799 P.1.j.037 Imaging neurophysiological dynamics underlying cognitive performance in a rat touch-screen reversal learning paradigm Tahon, K.
2015
25 S2 p. S353-S354
2 p.
artikel
800 P.1.j.016 Impact of smoking on cognitive functions Kim, S.
2015
25 S2 p. S342-
1 p.
artikel
801 P.1.j.027 Inflammatory markers and triiodothyronine concentrations are associated with impaired cognitive functioning after acute cardiac events Burkauskas, J.
2015
25 S2 p. S348-
1 p.
artikel
802 P.1.j.011 Involvement of hippocampal signaling pathways in dextromethorphan-induced memory impairment in rats Rezayof, A.
2015
25 S2 p. S339-
1 p.
artikel
803 P.1.j.015 IQ differences among relatives of schizophrenia patients: a comparative study Caldiroli, A.
2015
25 S2 p. S341-
1 p.
artikel
804 P.1.j.010 Lapses during on road driving: determining a cut-off value for clinically relevant driving impairment Van de Loo, A.J.A.E.
2015
25 S2 p. S338-
1 p.
artikel
805 P.1.j.012 Memantine treatment does not improve spatial learning in medial septal lesioned rats Beselia, G.
2015
25 S2 p. S339-S340
2 p.
artikel
806 P.1.j.003 Neuropsychological profiles in periventricular nodular heterotopia Kurzbuch, K.
2015
25 S2 p. S333-S334
2 p.
artikel
807 P.1.j.006 New neurocognitive endophenotype for major depressive episode: the role of working memory and implicit learning in the acute phase of depression Borbely-Ipkovich, E.
2015
25 S2 p. S335-S336
2 p.
artikel
808 P.1.j.038 Post-synaptic proteins and apolipoprotein E-mediated risk of Alzheimer's disease Sinclair, L.
2015
25 S2 p. S354-
1 p.
artikel
809 P.1.j.032 Protective effects of metformin in scopolamine-induced cognitive impairment in rats Aksoz, E.
2015
25 S2 p. S350-S351
2 p.
artikel
810 P.1.j.035 Reward sensitivity modulates associative learning in major depression – an eye-tracking study with 6 months follow-up Németh, V.L
2015
25 S2 p. S352-
1 p.
artikel
811 P.1.j.033 Social functioning and theory of mind in euthymic bipolar patients Alaya, S. Ben
2015
25 S2 p. S351-
1 p.
artikel
812 P.1.j.031 The efficacy of N-acetylcysteine on smoking cessation, impulsivity and cue reactivity in heavy smokers Schulte, M.H.J.
2015
25 S2 p. S350-
1 p.
artikel
813 P.1.j.002 The quality of life among first-episode psychotic patients Adamia, I.
2015
25 S2 p. S333-
1 p.
artikel
814 P.1.j.008 The relationship between cognitive impairment and depression, anxiety and virological response in hepatitis C patients in Egypt Bassiony, M.
2015
25 S2 p. S337-
1 p.
artikel
815 P.1.j.026 The retinal pathways as a model to understand brain damages in cannabis users Schwitzer, T.
2015
25 S2 p. S347-S348
2 p.
artikel
816 P.1.j.013 Time-based event expectancies in healthy ageing Kunchulia, M.
2015
25 S2 p. S340-
1 p.
artikel
817 P.1.j.021 Validation of a new, online cognitive assessment tool Domen, A.C
2015
25 S2 p. S344-
1 p.
artikel
818 P.1.k.033 A new platform to improve quality of PANNS and MADRS administration Detke, M.
2015
25 S2 p. S371-S372
2 p.
artikel
819 P.1.k.025 Are obstetrical complications really involved in the aetiology and outcome of psychotic and mood disorders? Bertino, V.
2015
25 S2 p. S367-
1 p.
artikel
820 P.1.k.018 Associations among psychosocial factor, medical factor and quality of life in patients with end-stage renal disease Woo, J.
2015
25 S2 p. S363-S364
2 p.
artikel
821 P.1.k.019 Attitudes of psychotherapists in medically-oriented and psychotherapeutically-oriented center towards pharmacotherapy in the course of psychotherapy Murawiec, S.
2015
25 S2 p. S364-
1 p.
artikel
822 P.1.k.027 Autoerotic and sexual activity in psychiatric patients Albanese, C.
2015
25 S2 p. S368-
1 p.
artikel
823 P.1.k.003 Borderline personality disorder experience in mental health centre Gomez, L. Pérez
2015
25 S2 p. S355-S356
2 p.
artikel
824 P.1.k.009 Borderline personality disorder revealed in Armenian population using DSM-5 criteria as screening tool Manvelyan, A.
2015
25 S2 p. S358-S359
2 p.
artikel
825 P.1.k.022 Changes of illicit opioid use among HIV-infected opioid users in Russia (2004–2014) Blokhina, E.A
2015
25 S2 p. S365-S366
2 p.
artikel
826 P.1.k.001 Clinical conditions relevant to the depressive mental states of Japanese patients with subacute myelo-optic neuropathy (SMON) Konishi, T.
2015
25 S2 p. S354-S355
2 p.
artikel
827 P.1.k.006 Collaborative care between clinical pharmacists and general practitioners in patients with polypharmacy: a focus on psychiatric and neurological drugs Stuhec, M.
2015
25 S2 p. S356-S357
2 p.
artikel
828 P.1.k.012 Correlation between ADHD and depression among university students in Macedonia Sushevska Panevska, L.
2015
25 S2 p. S360-
1 p.
artikel
829 P.1.k.017 Differences in the background characteristics of patients with severe and mild physical symptoms who attempted suicide by overdose Konishi, Y.
2015
25 S2 p. S363-
1 p.
artikel
830 P.1.k.011 Examination of self-esteem, body image, and past incidents of trauma in patients with obesity Tezcan, B.
2015
25 S2 p. S359-S360
2 p.
artikel
831 P.1.k.038 Experiences of family caregivers for persons with severe mental illness: an international exploration Vermeulen, B.
2015
25 S2 p. S374-
1 p.
artikel
832 P.1.k.005 Factors related to suicide attempts in a sample of schizophrenia patients Dumitru, M.M.
2015
25 S2 p. S356-
1 p.
artikel
833 P1.k.035 Gender difference among involuntarily admitted patients in a psychiatric service during 2014 Gonçalves, M.
2015
25 S2 p. S372-S373
2 p.
artikel
834 P.1.k.010 Influence of heavy metals on the Zangezur copper and molybdenum factory employees nervous system Galstyan, L.
2015
25 S2 p. S359-
1 p.
artikel
835 P1.k.030 Neuropsychological functioning as a risk factor for depression and anxiety disorders: A 10-year study in young people with parental psychopathology Bloemen, A.
2015
25 S2 p. S369-S370
2 p.
artikel
836 P.1.k.031 Personality traits and emotional profiles in severely obese patients in a preoperative evaluation Currò, V.
2015
25 S2 p. S370-S371
2 p.
artikel
837 P.1.k.021 PHQ9 validation in treatment seeking population in primary care settings in Latvia – the results of the pilot study of the National Research Project Vrublevska, J.
2015
25 S2 p. S365-
1 p.
artikel
838 P.1.k.029 Predictors of acute psychiatry hospitalisation from a home treatment team Chavarría Romero, V.
2015
25 S2 p. S369-
1 p.
artikel
839 P.1.k.013 Predictors of subjective successful aging in community-dwelling elderly: Comparing elders living alone and those living with others Shin, I.
2015
25 S2 p. S360-S361
2 p.
artikel
840 P.1.k.002 Prenatal psychotropic drug exposure, birth outcome and tendency to elective termination of pregnancy Oztürk, Z.
2015
25 S2 p. S355-
1 p.
artikel
841 P.1.k.037 Prescription survey of orexin receptor antagonist suvorexant Uno, J.
2015
25 S2 p. S373-S374
2 p.
artikel
842 P.1.k.008 Prevalence and factors related to depressive symptoms among Korean university students Kim, S.H.
2015
25 S2 p. S357-S358
2 p.
artikel
843 P.1.k.020 Prevalence of depressive symptoms and cognitive deterioration in elderly people Mahia, M.C. Garcia
2015
25 S2 p. S364-S365
2 p.
artikel
844 P.1.k.034 Psychomotor agitation in emergency medicine settings Taranto, F.
2015
25 S2 p. S372-
1 p.
artikel
845 P.1.k.007 Severity of anxiety and depression symptoms and health related quality of life among women with stress urinary incontinence Stepone, E.
2015
25 S2 p. S357-
1 p.
artikel
846 P.1.k.015 Sleep quality in psychiatric outpatients Fernández-Quintana, A.
2015
25 S2 p. S361-S362
2 p.
artikel
847 P.1.k.023 The prevalence and impact on insomnia of periodic limb movements during sleep in the Korean elderly Choi, J.H.
2015
25 S2 p. S366-S367
2 p.
artikel
848 P.1.k.028 The prevalence of adult separation anxiety disorder in patients with attention-deficit/hyperactivity disorder: a preliminary study from Turkey Ozten, E.
2015
25 S2 p. S368-S369
2 p.
artikel
849 P.1.k.026 The sociodemographic characteristics, habits, trends and forensic aspects of young male soldiers who applied to psychiatry clinic Ozmut, O.
2015
25 S2 p. S367-S368
2 p.
artikel
850 P.1.k.032 The Suicide Ideation and Behavior Assessment Tool: development of a novel measure of suicidal ideation and behavior and perceived risk of suicide Alphs, L.
2015
25 S2 p. S371-
1 p.
artikel
851 P.1.k.016 Turkish reliability and validity of psychopathy checklist revised Tutuncu, R.
2015
25 S2 p. S362-S363
2 p.
artikel
852 P.1.k.036 Type D personality and subjective sleep quality in coronary artery disease patients with and without sleep apnea Juskiene, A.
2015
25 S2 p. S373-
1 p.
artikel
853 P.1.k.014 Use of benzodiazepines in patients with hip fracture over 75 years Serrano, A.
2015
25 S2 p. S361-
1 p.
artikel
854 PL.06.01 Anxious temperament: results from a translational neuroscience approach Kalin, N.H.
2015
25 S2 p. S108-S109
2 p.
artikel
855 PL.02.01 Can we improve speed and efficacy of antidepressant treatments? Artigas, F.
2015
25 S2 p. S107-
1 p.
artikel
856 PL.05.01 Impulsivity and compulsivity: neural substrates and neuropsychiatric implications Robbins, T.W.
2015
25 S2 p. S108-
1 p.
artikel
857 PL.04.01 Is it time for immuno-psychiatry? Leboyer, M.
2015
25 S2 p. S108-
1 p.
artikel
858 PL.03.01 The role of motivation and reward in mental disorders Heinz, A.
2015
25 S2 p. S107-S108
2 p.
artikel
859 S.04.02 Abnormal myelin and axonal integrity in St8sia2 knockout mice – a model of polysialylation deficiency Wisniewska, M.B.
2015
25 S2 p. S115-
1 p.
artikel
860 S.12.02 A human pluripotent stem cell-derived neuronal model for characterisation of pathways regulating the autism and schizophrenia-related gene SHANK-3 Darville, H.
2015
25 S2 p. S127-
1 p.
artikel
861 S.12.05 Allosteric modulation of NMDA receptors rescues impaired synaptic plasticity in experimental Parkinsonism Nouhi, M.
2015
25 S2 p. S128-S129
2 p.
artikel
862 S.04.01 Alterations in structure and neurotransmission of cortical inhibitory networks in animal models and schizophrenic patients: role of the polysialylated form of the neural cell adhesion molecule NCAM Nacher, J.
2015
25 S2 p. S114-
1 p.
artikel
863 S.28.04 A mouse model to study the inflammation hypothesis of depression: from psychopathology to target discovery Pryce, C.
2015
25 S2 p. S151-
1 p.
artikel
864 S.28.01 Anna Monika Award Lecture – Interactions between neuroendocrine and inflammatory pathways in the pathogenesis of depression Pariante, C.M.
2015
25 S2 p. S150-
1 p.
artikel
865 S.11.04 Are endophenotypes a useful concept? Tamminga, C.A.
2015
25 S2 p. S126-S127
2 p.
artikel
866 S.10.01 Basic concepts of phMRI: interpretation and pitfalls Jenkins, B.
2015
25 S2 p. S124-
1 p.
artikel
867 S. 16.03 BDNF, depression and sleep: perspectives from animal models Stenberg, T.
2015
25 S2 p. S136-
1 p.
artikel
868 S.15.05 Behavioural transcriptomics; unique transcriptional programs across discrete brain regions encode behavioural experience Mukherjee, D.
2015
25 S2 p. S134-
1 p.
artikel
869 S.19.03 Biological dysfunction and translational aspects of mice carrying CNVs conferring high risk of schizophrenia Didriksen, M.
2015
25 S2 p. S140-
1 p.
artikel
870 S.26.03 Biomarkers for suicidal behaviour disorder Oquendo, M.A.
2015
25 S2 p. S149-
1 p.
artikel
871 S.26.04 Biomarkers of sensitivity to social stressors Courtet, P.
2015
25 S2 p. S149-
1 p.
artikel
872 S.25.03 Cannabinoid and glutamatergic targets for improving the treatment of maladaptive memory in fear and addiction Das, R.
2015
25 S2 p. S147-
1 p.
artikel
873 S.15.06 Cell cycle regulation of the progenitor cells from the adult hippocampal dentate gyrus in depression and by antidepressants Patricio, P.
2015
25 S2 p. S134-
1 p.
artikel
874 S.16.02 Chronotherapeutics to target the biological clock, heal depression and prevent suicide Benedetti, F.
2015
25 S2 p. S136-
1 p.
artikel
875 S.04.04 Clinical and brain structural correlates of NCAM and polysialic acid serum levels in schizophrenia Spalletta, G.
2015
25 S2 p. S115-S116
2 p.
artikel
876 S.22.01 Clinical and neuro-imaging characteristics of child and adolescent bipolar and schizophrenia offspring Hillegers, M.
2015
25 S2 p. S142-
1 p.
artikel
877 S.05.03 Cognitive-behavioural therapy as continuation treatment to sustain response after electroconvulsive therapy in depression (NCT00437385) Bajbouj, M.
2015
25 S2 p. S117-
1 p.
artikel
878 S.24.04 Cognitive deficits of schizophrenia and their control by the mTOR pathway Marin, P.
2015
25 S2 p. S146-
1 p.
artikel
879 S.06.04 Cognitive risk factors for schizophrenia spectrum disorders in children with 22q11.2DS Schneider, M.
2015
25 S2 p. S119-
1 p.
artikel
880 S.02.03 Combinatorial pharmacogenomics provides clinical validity and utility for treating major depression Altar, C.A.
2015
25 S2 p. S112-
1 p.
artikel
881 S.06.01 Copy number variations as risk and protective factors for schizophrenia in 22q11.2DS Van den Bree, M.B.M.
2015
25 S2 p. S118-
1 p.
artikel
882 S.03.03 Cue-induced brain activation and its association with automated and obsessive-compulsive alcohol consumption Vollstädt-Klein, S.
2015
25 S2 p. S113-S114
2 p.
artikel
883 S.02.04 Digital biomarkers for mood disorders Wicks, P.
2015
25 S2 p. S112-S113
2 p.
artikel
884 S. 12.08 Docosahexaenoic acid as a novel strategy for stress-related disorders: reversal of corticosterone-induced changes in cortical neurons Pusceddu, M.
2015
25 S2 p. S130-
1 p.
artikel
885 S.14.02 Dopaminergic function, choice impulsivity and cocaine use in cocaine-dependent humans Potenza, M.N.
2015
25 S2 p. S131-S132
2 p.
artikel
886 S.17.03 Double-blind crossed-over randomized controlled-trial with omega-3 fatty acids for autism spectrum disorders Parellada, M.
2015
25 S2 p. S138-
1 p.
artikel
887 S.03.02 Dynamic limbic inputs regulate striatal control of drug-seeking behaviour Murray, J.E.
2015
25 S2 p. S113-
1 p.
artikel
888 S.08.01 Early and time dependent effects of antidepressant treatments on rat hippocampal miRNome Tardito, D.
2015
25 S2 p. S121-
1 p.
artikel
889 S. 11.03 Effect of environmental risk factors and susceptibility genes for psychoses on brain structure and function Kircher, T.
2015
25 S2 p. S126-
1 p.
artikel
890 S.13.04 Effects of intranasal oxytocin or galantamine for primary enduring negative symptoms and cognitive impairments in people with schizophrenia Kelly, D.
2015
25 S2 p. S131-
1 p.
artikel
891 S.25.02 Effects of MDMA on self-referent encoding and personal memories: implications for its use in PTSD Curran, H.V.
2015
25 S2 p. S147-
1 p.
artikel
892 S.05.02 Efficacy and cognitive side effects of ultrabrief pulse electroconvulsive therapy (NTR1304) Sienaert, P.
2015
25 S2 p. S116-S117
2 p.
artikel
893 S.07.02 Epigenetic networks underlying compulsive disorders – evidence from animal and human studies Glennon, J.C.
2015
25 S2 p. S120-
1 p.
artikel
894 S.03.01 Establishment and escalation of cocaine use is determined by distinct patterns of striatal dopamine signalling Willuhn, I.
2015
25 S2 p. S113-
1 p.
artikel
895 S.17.01 Evidence-based pharmacological treatments in autism spectrum disorders: symptom targets McCracken, J.
2015
25 S2 p. S137-
1 p.
artikel
896 S.10.02 Experimental medicine with phMRI: study designs Mehta, M.
2015
25 S2 p. S124-S125
2 p.
artikel
897 S.22.03 Functional and structural MRI findings in child and adolescent offspring of bipolar patients Ladouceur, C.D.
2015
25 S2 p. S143-
1 p.
artikel
898 S.22.04 Functional and structural MRI in child and adolescent offspring of schizophrenia patients Keshavan, M.
2015
25 S2 p. S144-
1 p.
artikel
899 S.03.04 Functional changes in limbic and sensorimotor circuits in the development of cocaine addiction: results from human PET studies Leyton, M.
2015
25 S2 p. S114-
1 p.
artikel
900 S.08.03 Gene and microRNA expression in the mode of action of treatments for major depression Shomron, N.
2015
25 S2 p. S121-S122
2 p.
artikel
901 S.11.01 Gene-environment interaction and prefrontal cortical function as measured by fMRI Callicott, J.
2015
25 S2 p. S125-S126
2 p.
artikel
902 S.23.03 Genetic and epigenetic moderator of the first transcriptome response to stress: importance for stress-related psychiatric disorders? Binder, E.
2015
25 S2 p. S144-S145
2 p.
artikel
903 S.07.03 Genetic and pharmacological investigation of compulsive and impulsive behaviours Petryshen, T.L.
2015
25 S2 p. S120-
1 p.
artikel
904 S.01.01 Genetic dissection of anxiety disorders: can ‘separation anxiety disorder’ be distinguished? Domschke, K.
2015
25 S2 p. S111-
1 p.
artikel
905 S.26.01 Genetics of suicidal behaviour: a review of the evidence Sokolowski, M.
2015
25 S2 p. S148-
1 p.
artikel
906 S.26.02 Genomics research in suicidology Rujescu, D.
2015
25 S2 p. S148-S149
2 p.
artikel
907 S. 14.03 Goal-directed and habit-based decision making: computational modelling in alcohol dependence and related disorders Sjoerds, Z.
2015
25 S2 p. S132-
1 p.
artikel
908 S.20.04 Gut-brain communication: how the microbiome influences anxiety and depression Foster, J.
2015
25 S2 p. S141-
1 p.
artikel
909 S.14.04 How a stick becomes a reward to reinforce compulsivity in OCD: implications for addiction Yücel, M.
2015
25 S2 p. S132-S133
2 p.
artikel
910 S.21.02 How to rescue CNS active drugs which fail in one indication: experience from the ECNP Medicines Chest Initiative Nutt, D.
2015
25 S2 p. S141-S142
2 p.
artikel
911 S.15.03 Hyperresponsiveness of the neural fear network in cocaine abuse disorder Kaag, A.M.
2015
25 S2 p. S134-
1 p.
artikel
912 S.28.03 Inflammation and adult hippocampal neurogenesis Nolan, Y.
2015
25 S2 p. S151-
1 p.
artikel
913 S.16.01 Is the vesicular glutamate transporter type 3 (VGLUT3) a novel marker linking mood to sleep? A study in VGLUT3 deficient mice Fabre, V.
2015
25 S2 p. S136-
1 p.
artikel
914 S.12.07 Ketamine rapidly rescues IL-1β-induced changes in synaptic plasticity and cytokines in human neurons Tojo, L.M.
2015
25 S2 p. S129-
1 p.
artikel
915 S.18.03 Machine learning as a tool to assist in diagnosis Nieuwenhuis, M.
2015
25 S2 p. S138-S139
2 p.
artikel
916 S.12.04 Melanocortin MC4 receptor agonists induce neuroprotection and neurogenesis in a transgenic mouse model of moderate Alzheimer's disease Neri, L.
2015
25 S2 p. S128-
1 p.
artikel
917 S.08.04 miRNA genomic studies in mood disorders: new susceptibility variants and molecular markers Chiavetto, L. Bocchio
2015
25 S2 p. S122-
1 p.
artikel
918 S.08.02 miRNA predictors and correlates of antidepressant response Turecki, G.
2015
25 S2 p. S121-
1 p.
artikel
919 S.15.01 Modelling psychiatric endophenotypes and disrupted circuits by chemogenetic activation of dopamine neurons Boekhoudt, L.
2015
25 S2 p. S133-
1 p.
artikel
920 S.12.03 Modulation of glutamatergic transmission in the infralimbic cortex evokes antidepressant-like effects in rats Gasull-Camós, J.
2015
25 S2 p. S127-S128
2 p.
artikel
921 S.25.01 Molecular mechanisms underlying emotional memories: importance to target fear Krugers, H.
2015
25 S2 p. S147-
1 p.
artikel
922 S.24.01 mTOR controls structural plasticity of dopaminergic neurons: implication in the actions of ketamine Collo, G.
2015
25 S2 p. S145-S146
2 p.
artikel
923 S.12.06 Mutation repair as a therapeutic strategy for Rett syndrome Ross, P.
2015
25 S2 p. S129-
1 p.
artikel
924 S.15.07 Neural correlates of impulsivity as a marker of disordered eating in adolescents Bartholdy, S.
2015
25 S2 p. S135-
1 p.
artikel
925 S.15.02 Neural responses during response inhibition and anticipation of reward in healthy controls and in drug-dependent individuals Fazal, M.
2015
25 S2 p. S133-
1 p.
artikel
926 S.06.03 Neurobiological risk factors for schizophrenia in adults with 22q11.2DS Van Amelsvoort, T.
2015
25 S2 p. S118-S119
2 p.
artikel
927 S.01.03 Neurobiology of adult separation anxiety disorder Redlich, R.
2015
25 S2 p. S111-S112
2 p.
artikel
928 S.07.04 Neuroimmunological regulators of compulsivity Adriani, W.
2015
25 S2 p. S120-S121
2 p.
artikel
929 S.15.08 Neuroinflammation in schizophrenia and effects of antipsychotic medication – a PET study Holmes, S.E.
2015
25 S2 p. S135-
1 p.
artikel
930 S.25.04 Noradrenergic manipulation of fear memory reconsolidation: a new treatment for anxiety disorders Kindt, M.
2015
25 S2 p. S148-
1 p.
artikel
931 S.27.01 Novel developments in machine learning techniques for neuroimaging Schnack, H.
2015
25 S2 p. S149-S150
2 p.
artikel
932 S.17.04 Oxytocin in the treatment of autism spectrum disorders Alvares, G.
2015
25 S2 p. S138-
1 p.
artikel
933 S.09.04 Oxytocin therapy for FTD Finger, E.
2015
25 S2 p. S124-
1 p.
artikel
934 S.18.04 PET to predict treatment response and outcome Howes, O.
2015
25 S2 p. S139-
1 p.
artikel
935 S.12.01 Pharmacological modulation of excitatory/inhibitory balance in autism spectrum disorder Ajram, L.
2015
25 S2 p. S127-
1 p.
artikel
936 S.09.01 Pharmacological treatment of frontal lobe dementia: recent advances Boxer, A.
2015
25 S2 p. S122-S123
2 p.
artikel
937 S.10.03 phMRI brain imaging of monoaminergic systems Reneman, L.
2015
25 S2 p. S125-
1 p.
artikel
938 S.10.04 phMRI in emotional processing Del-Ben, C.M.
2015
25 S2 p. S125-
1 p.
artikel
939 S.20.02 Prebiotics and anxiety: translational studies toward new therapeutic strategies Burnet, P.W.
2015
25 S2 p. S141-
1 p.
artikel
940 S.27.04 Predicting treatment outcome using resting-state fMRI Van Wingen, G.
2015
25 S2 p. S150-
1 p.
artikel
941 S.05.04 Prolonging remission in depressed elderly (PRIDE; NCT01028508) Kellner, C.
2015
25 S2 p. S117-
1 p.
artikel
942 S.13.03 RCT administering oxytocin for schizophrenia, a three week add-on study Weiser, M.
2015
25 S2 p. S130-S131
2 p.
artikel
943 S.24.02 Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives prefrontal cortex development via the mTOR pathway Chavis, P.
2015
25 S2 p. S146-
1 p.
artikel
944 S.06.02 Risk factors for schizophrenia and psychiatric treatments in 22q11.2 deletion syndrome Gothelf, D.
2015
25 S2 p. S118-
1 p.
artikel
945 S.28.02 Role of kynurenine and glutamate in inflammation-induced depression Dantzer, R.
2015
25 S2 p. S150-S151
2 p.
artikel
946 S.09.03 Serotonergic parameters in the treatment of FTD Lanctot, K.L.
2015
25 S2 p. S123-
1 p.
artikel
947 S.09.02 Serotonin restores electrophysiological signatures of inhibition Rowe, J.
2015
25 S2 p. S123-
1 p.
artikel
948 S.16.04 Sleep-related neuroplasticity in major depression Dresler, M.
2015
25 S2 p. S136-S137
2 p.
artikel
949 S. 19.04 Speeding up drug development: results of a public private partnership Stensbol, T.B.
2015
25 S2 p. S140-
1 p.
artikel
950 S.19.02 Structural and functional imaging effects of CNVs in mouse and man Gass, N.
2015
25 S2 p. S139-S140
2 p.
artikel
951 S.22.02 Structural MRI characteristics of child and adolescent offspring of schizophrenia and bipolar patients Sugranyes, G.
2015
25 S2 p. S143-
1 p.
artikel
952 S.04.03 St8sia2 deficiency plus juvenile cannabis exposure synergistically affect higher cognition in adulthood Ehrenreich, H.
2015
25 S2 p. S115-
1 p.
artikel
953 S.13.01 The brain oxytocin system: regulation of a socio-emotional balance in health and disease Neumann, I.
2015
25 S2 p. S130-
1 p.
artikel
954 S.01.04 The CO2 experimental medicine model of anxiety Garner, M.
2015
25 S2 p. S112-
1 p.
artikel
955 S.05.01 The EFFECT-Dep Trial – a randomised trial of bitemporal and high-dose unilateral ECT for depression (ISRCTN23577151) McLoughlin, D.
2015
25 S2 p. S116-
1 p.
artikel
956 S.20.01 The microbiome-gut-brain axis: how bacteria can cause mood and psychotic disorders Cryan, J.F.
2015
25 S2 p. S140-S141
2 p.
artikel
957 S.17.02 The role of melatonin in the treatment of ASD Frye, R.
2015
25 S2 p. S137-
1 p.
artikel
958 S.23.01 The stress impact on synaptic function and brain architecture: a key to mood and anxiety disorders Musazzi, L.
2015
25 S2 p. S144-
1 p.
artikel
959 S.14.01 The transition into dependence: from impulsivity to habit formation in addiction – a theoretical update and overview of translational research in human neuroscience Luijten, M.
2015
25 S2 p. S131-
1 p.
artikel
960 S.23.04 The two faces of stress: from neuronal responses to cognitive behaviours Yan, Z.
2015
25 S2 p. S145-
1 p.
artikel
961 S.21.04 To what extent can observational patient-level databases supplant the need for randomized clinical trials? Stang, P.
2015
25 S2 p. S142-
1 p.
artikel
962 S.07.01 Translational approaches to understanding compulsivity as a cross disorder trait Voon, V.
2015
25 S2 p. S119-
1 p.
artikel
963 S.11.02 Use of imaging and genetics in drug development Bertolino, A.
2015
25 S2 p. S126-
1 p.
artikel
                             963 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland